id	sid	tid	token	lemma	pos
cord-350182-s10nong7	1	1	key	key	NNP
cord-350182-s10nong7	1	2	:	:	:
cord-350182-s10nong7	1	3	cord-350182-s10nong7	cord-350182-s10nong7	NN
cord-350182-s10nong7	1	4	authors	author	NNS
cord-350182-s10nong7	1	5	:	:	:
cord-350182-s10nong7	1	6	Milionis	Milionis	NNP
cord-350182-s10nong7	1	7	,	,	,
cord-350182-s10nong7	1	8	Charalampos	Charalampos	NNP
cord-350182-s10nong7	1	9	;	;	:
cord-350182-s10nong7	1	10	Milioni	Milioni	NNP
cord-350182-s10nong7	1	11	,	,	,
cord-350182-s10nong7	1	12	Stella	Stella	NNP
cord-350182-s10nong7	1	13	Olga	Olga	NNP
cord-350182-s10nong7	2	1	title	title	NN
cord-350182-s10nong7	2	2	:	:	:
cord-350182-s10nong7	2	3	A	a	DT
cord-350182-s10nong7	2	4	brief	brief	JJ
cord-350182-s10nong7	2	5	analysis	analysis	NN
cord-350182-s10nong7	2	6	and	and	CC
cord-350182-s10nong7	2	7	hypotheses	hypothesis	NNS
cord-350182-s10nong7	2	8	about	about	IN
cord-350182-s10nong7	2	9	the	the	DT
cord-350182-s10nong7	2	10	risk	risk	NN
cord-350182-s10nong7	2	11	of	of	IN
cord-350182-s10nong7	2	12	COVID-19	COVID-19	NNP
cord-350182-s10nong7	2	13	for	for	IN
cord-350182-s10nong7	2	14	people	people	NNS
cord-350182-s10nong7	2	15	with	with	IN
cord-350182-s10nong7	2	16	type	type	NN
cord-350182-s10nong7	2	17	1	1	CD
cord-350182-s10nong7	2	18	and	and	CC
cord-350182-s10nong7	2	19	type	type	NN
cord-350182-s10nong7	2	20	2	2	CD
cord-350182-s10nong7	2	21	diabetes	diabetes	NN
cord-350182-s10nong7	2	22	mellitus	mellitus	NN
cord-350182-s10nong7	2	23	date	date	NN
cord-350182-s10nong7	2	24	:	:	:
cord-350182-s10nong7	2	25	2020	2020	CD
cord-350182-s10nong7	2	26	-	-	HYPH
cord-350182-s10nong7	2	27	07	07	CD
cord-350182-s10nong7	2	28	-	-	HYPH
cord-350182-s10nong7	2	29	20	20	CD
cord-350182-s10nong7	2	30	journal	journal	NN
cord-350182-s10nong7	2	31	:	:	:
cord-350182-s10nong7	2	32	J	J	NNP
cord-350182-s10nong7	2	33	Diabetes	diabetes	NN
cord-350182-s10nong7	2	34	Metab	Metab	NNP
cord-350182-s10nong7	2	35	Disord	Disord	NNP
cord-350182-s10nong7	2	36	DOI	doi	NN
cord-350182-s10nong7	2	37	:	:	:
cord-350182-s10nong7	2	38	10.1007	10.1007	CD
cord-350182-s10nong7	2	39	/	/	SYM
cord-350182-s10nong7	2	40	s40200	s40200	NN
cord-350182-s10nong7	2	41	-	-	HYPH
cord-350182-s10nong7	2	42	020	020	CD
cord-350182-s10nong7	2	43	-	-	HYPH
cord-350182-s10nong7	2	44	00592	00592	CD
cord-350182-s10nong7	2	45	-	-	SYM
cord-350182-s10nong7	2	46	3	3	CD
cord-350182-s10nong7	2	47	sha	sha	NNP
cord-350182-s10nong7	2	48	:	:	:
cord-350182-s10nong7	2	49	1a267b4c89606d2b62aa6340f23f39c3145351ef	1a267b4c89606d2b62aa6340f23f39c3145351ef	CD
cord-350182-s10nong7	2	50	doc_id	doc_id	CD
cord-350182-s10nong7	2	51	:	:	:
cord-350182-s10nong7	2	52	350182	350182	CD
cord-350182-s10nong7	2	53	cord_uid	cord_uid	NNS
cord-350182-s10nong7	2	54	:	:	:
cord-350182-s10nong7	2	55	s10nong7	s10nong7	NNP
cord-350182-s10nong7	3	1	COVID-19	COVID-19	NNP
cord-350182-s10nong7	3	2	is	be	VBZ
cord-350182-s10nong7	3	3	an	an	DT
cord-350182-s10nong7	3	4	infectious	infectious	JJ
cord-350182-s10nong7	3	5	respiratory	respiratory	JJ
cord-350182-s10nong7	3	6	disease	disease	NN
cord-350182-s10nong7	3	7	which	which	WDT
cord-350182-s10nong7	3	8	firstly	firstly	RB
cord-350182-s10nong7	3	9	occurred	occur	VBD
cord-350182-s10nong7	3	10	in	in	IN
cord-350182-s10nong7	3	11	Wuhan	Wuhan	NNP
cord-350182-s10nong7	3	12	,	,	,
cord-350182-s10nong7	3	13	China	China	NNP
cord-350182-s10nong7	3	14	and	and	CC
cord-350182-s10nong7	3	15	evolved	evolve	VBD
cord-350182-s10nong7	3	16	rapidly	rapidly	RB
cord-350182-s10nong7	3	17	around	around	IN
cord-350182-s10nong7	3	18	the	the	DT
cord-350182-s10nong7	3	19	globe	globe	NN
cord-350182-s10nong7	3	20	.	.	.
cord-350182-s10nong7	4	1	The	the	DT
cord-350182-s10nong7	4	2	causative	causative	JJ
cord-350182-s10nong7	4	3	pathogen	pathogen	NN
cord-350182-s10nong7	4	4	is	be	VBZ
cord-350182-s10nong7	4	5	a	a	DT
cord-350182-s10nong7	4	6	novel	novel	JJ
cord-350182-s10nong7	4	7	coronavirus	coronavirus	NN
cord-350182-s10nong7	4	8	called	call	VBN
cord-350182-s10nong7	4	9	SARS	SARS	NNP
cord-350182-s10nong7	4	10	-	-	HYPH
cord-350182-s10nong7	4	11	CoV-2	CoV-2	NNP
cord-350182-s10nong7	4	12	with	with	IN
cord-350182-s10nong7	4	13	genomic	genomic	JJ
cord-350182-s10nong7	4	14	similarities	similarity	NNS
cord-350182-s10nong7	4	15	with	with	IN
cord-350182-s10nong7	4	16	SARS	SARS	NNP
cord-350182-s10nong7	4	17	-	-	HYPH
cord-350182-s10nong7	4	18	CoV	CoV	NNP
cord-350182-s10nong7	4	19	and	and	CC
cord-350182-s10nong7	4	20	MERS-	MERS-	NNP
cord-350182-s10nong7	5	1	CoV.	CoV.	NNP
cord-350182-s10nong7	6	1	The	the	DT
cord-350182-s10nong7	6	2	disease	disease	NN
cord-350182-s10nong7	6	3	is	be	VBZ
cord-350182-s10nong7	6	4	transmitted	transmit	VBN
cord-350182-s10nong7	6	5	among	among	IN
cord-350182-s10nong7	6	6	humans	human	NNS
cord-350182-s10nong7	6	7	either	either	CC
cord-350182-s10nong7	6	8	through	through	IN
cord-350182-s10nong7	6	9	direct	direct	JJ
cord-350182-s10nong7	6	10	contact	contact	NN
cord-350182-s10nong7	6	11	or	or	CC
cord-350182-s10nong7	6	12	via	via	IN
cord-350182-s10nong7	6	13	droplets	droplet	NNS
cord-350182-s10nong7	6	14	from	from	IN
cord-350182-s10nong7	6	15	sneeze	sneeze	NN
cord-350182-s10nong7	6	16	or	or	CC
cord-350182-s10nong7	6	17	cough	cough	NN
cord-350182-s10nong7	6	18	.	.	.
cord-350182-s10nong7	7	1	Most	Most	JJS
cord-350182-s10nong7	7	2	infected	infected	JJ
cord-350182-s10nong7	7	3	persons	person	NNS
cord-350182-s10nong7	7	4	remain	remain	VBP
cord-350182-s10nong7	7	5	asymptomatic	asymptomatic	JJ
cord-350182-s10nong7	7	6	or	or	CC
cord-350182-s10nong7	7	7	mildly	mildly	RB
cord-350182-s10nong7	7	8	symptomatic	symptomatic	JJ
cord-350182-s10nong7	7	9	,	,	,
cord-350182-s10nong7	7	10	but	but	CC
cord-350182-s10nong7	7	11	some	some	DT
cord-350182-s10nong7	7	12	patients	patient	NNS
cord-350182-s10nong7	7	13	may	may	MD
cord-350182-s10nong7	7	14	develop	develop	VB
cord-350182-s10nong7	7	15	severe	severe	JJ
cord-350182-s10nong7	7	16	clinical	clinical	JJ
cord-350182-s10nong7	7	17	features	feature	NNS
cord-350182-s10nong7	7	18	,	,	,
cord-350182-s10nong7	7	19	including	include	VBG
cord-350182-s10nong7	7	20	pneumonia	pneumonia	NN
cord-350182-s10nong7	7	21	,	,	,
cord-350182-s10nong7	7	22	respiratory	respiratory	JJ
cord-350182-s10nong7	7	23	failure	failure	NN
cord-350182-s10nong7	7	24	,	,	,
cord-350182-s10nong7	7	25	sepsis	sepsis	NN
cord-350182-s10nong7	7	26	and	and	CC
cord-350182-s10nong7	7	27	even	even	RB
cord-350182-s10nong7	7	28	death	death	NN
cord-350182-s10nong7	7	29	.	.	.
cord-350182-s10nong7	8	1	People	People	NNS
cord-350182-s10nong7	8	2	of	of	IN
cord-350182-s10nong7	8	3	advanced	advanced	JJ
cord-350182-s10nong7	8	4	age	age	NN
cord-350182-s10nong7	8	5	and/or	and/or	CC
cord-350182-s10nong7	8	6	with	with	IN
cord-350182-s10nong7	8	7	underlying	underlie	VBG
cord-350182-s10nong7	8	8	diseases	disease	NNS
cord-350182-s10nong7	8	9	(	(	-LRB-
cord-350182-s10nong7	8	10	including	include	VBG
cord-350182-s10nong7	8	11	diabetes	diabetes	NN
cord-350182-s10nong7	8	12	mellitus	mellitus	NN
cord-350182-s10nong7	8	13	)	)	-RRB-
cord-350182-s10nong7	8	14	are	be	VBP
cord-350182-s10nong7	8	15	at	at	IN
cord-350182-s10nong7	8	16	greater	great	JJR
cord-350182-s10nong7	8	17	risk	risk	NN
cord-350182-s10nong7	8	18	.	.	.
cord-350182-s10nong7	9	1	The	the	DT
cord-350182-s10nong7	9	2	innate	innate	JJ
cord-350182-s10nong7	9	3	and	and	CC
cord-350182-s10nong7	9	4	adaptive	adaptive	JJ
cord-350182-s10nong7	9	5	immune	immune	JJ
cord-350182-s10nong7	9	6	system	system	NN
cord-350182-s10nong7	9	7	are	be	VBP
cord-350182-s10nong7	9	8	responsible	responsible	JJ
cord-350182-s10nong7	9	9	for	for	IN
cord-350182-s10nong7	9	10	protecting	protect	VBG
cord-350182-s10nong7	9	11	the	the	DT
cord-350182-s10nong7	9	12	body	body	NN
cord-350182-s10nong7	9	13	against	against	IN
cord-350182-s10nong7	9	14	viral	viral	JJ
cord-350182-s10nong7	9	15	infection	infection	NN
cord-350182-s10nong7	9	16	.	.	.
cord-350182-s10nong7	10	1	Nevertheless	nevertheless	RB
cord-350182-s10nong7	10	2	,	,	,
cord-350182-s10nong7	10	3	it	-PRON-	PRP
cord-350182-s10nong7	10	4	is	be	VBZ
cord-350182-s10nong7	10	5	assumed	assume	VBN
cord-350182-s10nong7	10	6	that	that	IN
cord-350182-s10nong7	10	7	SARS	SARS	NNP
cord-350182-s10nong7	10	8	-	-	HYPH
cord-350182-s10nong7	10	9	CoV-2	CoV-2	NNP
cord-350182-s10nong7	10	10	interferes	interfere	VBZ
cord-350182-s10nong7	10	11	with	with	IN
cord-350182-s10nong7	10	12	the	the	DT
cord-350182-s10nong7	10	13	immune	immune	JJ
cord-350182-s10nong7	10	14	system	system	NN
cord-350182-s10nong7	10	15	through	through	IN
cord-350182-s10nong7	10	16	immunomodulating	immunomodulating	JJ
cord-350182-s10nong7	10	17	mechanisms	mechanism	NNS
cord-350182-s10nong7	10	18	which	which	WDT
cord-350182-s10nong7	10	19	intensify	intensify	VBP
cord-350182-s10nong7	10	20	its	-PRON-	PRP$
cord-350182-s10nong7	10	21	pathogenesis	pathogenesis	NN
cord-350182-s10nong7	10	22	.	.	.
cord-350182-s10nong7	11	1	A	a	DT
cord-350182-s10nong7	11	2	delayed	delayed	JJ
cord-350182-s10nong7	11	3	or	or	CC
cord-350182-s10nong7	11	4	reduced	reduce	VBN
cord-350182-s10nong7	11	5	response	response	NN
cord-350182-s10nong7	11	6	of	of	IN
cord-350182-s10nong7	11	7	the	the	DT
cord-350182-s10nong7	11	8	innate	innate	JJ
cord-350182-s10nong7	11	9	immune	immune	JJ
cord-350182-s10nong7	11	10	system	system	NN
cord-350182-s10nong7	11	11	is	be	VBZ
cord-350182-s10nong7	11	12	critical	critical	JJ
cord-350182-s10nong7	11	13	for	for	IN
cord-350182-s10nong7	11	14	the	the	DT
cord-350182-s10nong7	11	15	development	development	NN
cord-350182-s10nong7	11	16	of	of	IN
cord-350182-s10nong7	11	17	pathogenesis	pathogenesis	NN
cord-350182-s10nong7	11	18	of	of	IN
cord-350182-s10nong7	11	19	the	the	DT
cord-350182-s10nong7	11	20	virus	virus	NN
cord-350182-s10nong7	11	21	.	.	.
cord-350182-s10nong7	12	1	People	People	NNS
cord-350182-s10nong7	12	2	with	with	IN
cord-350182-s10nong7	12	3	diabetes	diabete	NNS
cord-350182-s10nong7	12	4	are	be	VBP
cord-350182-s10nong7	12	5	more	more	RBR
cord-350182-s10nong7	12	6	likely	likely	JJ
cord-350182-s10nong7	12	7	to	to	TO
cord-350182-s10nong7	12	8	develop	develop	VB
cord-350182-s10nong7	12	9	severe	severe	JJ
cord-350182-s10nong7	12	10	symptoms	symptom	NNS
cord-350182-s10nong7	12	11	of	of	IN
cord-350182-s10nong7	12	12	COVID-19	COVID-19	NNP
cord-350182-s10nong7	12	13	.	.	.
cord-350182-s10nong7	13	1	The	the	DT
cord-350182-s10nong7	13	2	present	present	JJ
cord-350182-s10nong7	13	3	article	article	NN
cord-350182-s10nong7	13	4	speculates	speculate	VBZ
cord-350182-s10nong7	13	5	that	that	IN
cord-350182-s10nong7	13	6	special	special	JJ
cord-350182-s10nong7	13	7	aspects	aspect	NNS
cord-350182-s10nong7	13	8	of	of	IN
cord-350182-s10nong7	13	9	the	the	DT
cord-350182-s10nong7	13	10	immune	immune	JJ
cord-350182-s10nong7	13	11	dysfunction	dysfunction	NN
cord-350182-s10nong7	13	12	caused	cause	VBN
cord-350182-s10nong7	13	13	by	by	IN
cord-350182-s10nong7	13	14	chronic	chronic	JJ
cord-350182-s10nong7	13	15	hyperglycaemia	hyperglycaemia	NN
cord-350182-s10nong7	13	16	is	be	VBZ
cord-350182-s10nong7	13	17	the	the	DT
cord-350182-s10nong7	13	18	main	main	JJ
cord-350182-s10nong7	13	19	reason	reason	NN
cord-350182-s10nong7	13	20	for	for	IN
cord-350182-s10nong7	13	21	this	this	DT
cord-350182-s10nong7	13	22	susceptibility	susceptibility	NN
cord-350182-s10nong7	13	23	.	.	.
cord-350182-s10nong7	14	1	Coronavirus	Coronavirus	NNP
cord-350182-s10nong7	14	2	disease	disease	NN
cord-350182-s10nong7	14	3	2019	2019	CD
cord-350182-s10nong7	14	4	(	(	-LRB-
cord-350182-s10nong7	14	5	COVID-19	COVID-19	NNP
cord-350182-s10nong7	14	6	)	)	-RRB-
cord-350182-s10nong7	14	7	is	be	VBZ
cord-350182-s10nong7	14	8	a	a	DT
cord-350182-s10nong7	14	9	respiratory	respiratory	JJ
cord-350182-s10nong7	14	10	infection	infection	NN
cord-350182-s10nong7	14	11	which	which	WDT
cord-350182-s10nong7	14	12	is	be	VBZ
cord-350182-s10nong7	14	13	caused	cause	VBN
cord-350182-s10nong7	14	14	by	by	IN
cord-350182-s10nong7	14	15	a	a	DT
cord-350182-s10nong7	14	16	novel	novel	JJ
cord-350182-s10nong7	14	17	virus	virus	NN
cord-350182-s10nong7	14	18	belonging	belong	VBG
cord-350182-s10nong7	14	19	to	to	IN
cord-350182-s10nong7	14	20	the	the	DT
cord-350182-s10nong7	14	21	Coronaviridae	Coronaviridae	NNP
cord-350182-s10nong7	14	22	family	family	NN
cord-350182-s10nong7	14	23	[	[	-LRB-
cord-350182-s10nong7	14	24	1	1	CD
cord-350182-s10nong7	14	25	]	]	-RRB-
cord-350182-s10nong7	14	26	and	and	CC
cord-350182-s10nong7	14	27	is	be	VBZ
cord-350182-s10nong7	14	28	officially	officially	RB
cord-350182-s10nong7	14	29	named	name	VBN
cord-350182-s10nong7	14	30	SARS	SARS	NNP
cord-350182-s10nong7	14	31	-	-	HYPH
cord-350182-s10nong7	14	32	CoV-2	CoV-2	NNP
cord-350182-s10nong7	14	33	(	(	-LRB-
cord-350182-s10nong7	14	34	severe	severe	JJ
cord-350182-s10nong7	14	35	acute	acute	JJ
cord-350182-s10nong7	14	36	respiratory	respiratory	JJ
cord-350182-s10nong7	14	37	syndrome	syndrome	NN
cord-350182-s10nong7	14	38	coronavirus	coronavirus	NN
cord-350182-s10nong7	14	39	2	2	CD
cord-350182-s10nong7	14	40	)	)	-RRB-
cord-350182-s10nong7	14	41	.	.	.
cord-350182-s10nong7	15	1	In	in	IN
cord-350182-s10nong7	15	2	humans	human	NNS
cord-350182-s10nong7	15	3	,	,	,
cord-350182-s10nong7	15	4	coronaviruses	coronaviruse	NNS
cord-350182-s10nong7	15	5	primarily	primarily	RB
cord-350182-s10nong7	15	6	target	target	VBP
cord-350182-s10nong7	15	7	the	the	DT
cord-350182-s10nong7	15	8	respiratory	respiratory	JJ
cord-350182-s10nong7	15	9	system	system	NN
cord-350182-s10nong7	15	10	and	and	CC
cord-350182-s10nong7	15	11	have	have	VBP
cord-350182-s10nong7	15	12	also	also	RB
cord-350182-s10nong7	15	13	caused	cause	VBN
cord-350182-s10nong7	15	14	outbreaks	outbreak	NNS
cord-350182-s10nong7	15	15	of	of	IN
cord-350182-s10nong7	15	16	respiratory	respiratory	JJ
cord-350182-s10nong7	15	17	disease	disease	NN
cord-350182-s10nong7	15	18	in	in	IN
cord-350182-s10nong7	15	19	the	the	DT
cord-350182-s10nong7	15	20	past	past	NN
cord-350182-s10nong7	15	21	,	,	,
cord-350182-s10nong7	15	22	mainly	mainly	RB
cord-350182-s10nong7	15	23	the	the	DT
cord-350182-s10nong7	15	24	severe	severe	JJ
cord-350182-s10nong7	15	25	acute	acute	JJ
cord-350182-s10nong7	15	26	respiratory	respiratory	JJ
cord-350182-s10nong7	15	27	syndrome	syndrome	NN
cord-350182-s10nong7	15	28	(	(	-LRB-
cord-350182-s10nong7	15	29	SARS	SARS	NNP
cord-350182-s10nong7	15	30	-	-	HYPH
cord-350182-s10nong7	15	31	CoV	CoV	NNP
cord-350182-s10nong7	15	32	)	)	-RRB-
cord-350182-s10nong7	15	33	in	in	IN
cord-350182-s10nong7	15	34	2003	2003	CD
cord-350182-s10nong7	15	35	and	and	CC
cord-350182-s10nong7	15	36	the	the	DT
cord-350182-s10nong7	15	37	Middle	Middle	NNP
cord-350182-s10nong7	15	38	East	East	NNP
cord-350182-s10nong7	15	39	respiratory	respiratory	JJ
cord-350182-s10nong7	15	40	syndrome	syndrome	NN
cord-350182-s10nong7	15	41	(	(	-LRB-
cord-350182-s10nong7	15	42	MERS	MERS	NNP
cord-350182-s10nong7	15	43	-	-	HYPH
cord-350182-s10nong7	15	44	CoV	CoV	NNP
cord-350182-s10nong7	15	45	)	)	-RRB-
cord-350182-s10nong7	15	46	in	in	IN
cord-350182-s10nong7	15	47	2012	2012	CD
cord-350182-s10nong7	15	48	.	.	.
cord-350182-s10nong7	16	1	They	-PRON-	PRP
cord-350182-s10nong7	16	2	are	be	VBP
cord-350182-s10nong7	16	3	a	a	DT
cord-350182-s10nong7	16	4	large	large	JJ
cord-350182-s10nong7	16	5	family	family	NN
cord-350182-s10nong7	16	6	of	of	IN
cord-350182-s10nong7	16	7	positivesense	positivesense	NN
cord-350182-s10nong7	16	8	single	single	RB
cord-350182-s10nong7	16	9	-	-	HYPH
cord-350182-s10nong7	16	10	stranded	strand	VBN
cord-350182-s10nong7	16	11	RNA	RNA	NNP
cord-350182-s10nong7	16	12	viruses	virus	NNS
cord-350182-s10nong7	16	13	(	(	-LRB-
cord-350182-s10nong7	16	14	+	+	CC
cord-350182-s10nong7	16	15	ssRNA	ssRNA	-RRB-
cord-350182-s10nong7	16	16	)	)	-RRB-
cord-350182-s10nong7	16	17	with	with	IN
cord-350182-s10nong7	16	18	a	a	DT
cord-350182-s10nong7	16	19	crownlike	crownlike	JJ
cord-350182-s10nong7	16	20	appearance	appearance	NN
cord-350182-s10nong7	16	21	under	under	IN
cord-350182-s10nong7	16	22	the	the	DT
cord-350182-s10nong7	16	23	electron	electron	NN
cord-350182-s10nong7	16	24	microscope	microscope	NN
cord-350182-s10nong7	16	25	due	due	IN
cord-350182-s10nong7	16	26	to	to	IN
cord-350182-s10nong7	16	27	the	the	DT
cord-350182-s10nong7	16	28	presence	presence	NN
cord-350182-s10nong7	16	29	of	of	IN
cord-350182-s10nong7	16	30	spike	spike	NN
cord-350182-s10nong7	16	31	glycoproteins	glycoprotein	NNS
cord-350182-s10nong7	16	32	on	on	IN
cord-350182-s10nong7	16	33	the	the	DT
cord-350182-s10nong7	16	34	envelope	envelope	NN
cord-350182-s10nong7	16	35	[	[	-LRB-
cord-350182-s10nong7	16	36	2	2	CD
cord-350182-s10nong7	16	37	]	]	-RRB-
cord-350182-s10nong7	16	38	.	.	.
cord-350182-s10nong7	17	1	These	these	DT
cord-350182-s10nong7	17	2	viruses	virus	NNS
cord-350182-s10nong7	17	3	derive	derive	VBP
cord-350182-s10nong7	17	4	from	from	IN
cord-350182-s10nong7	17	5	animal	animal	NN
cord-350182-s10nong7	17	6	species	specie	NNS
cord-350182-s10nong7	17	7	(	(	-LRB-
cord-350182-s10nong7	17	8	bats	bat	NNS
cord-350182-s10nong7	17	9	,	,	,
cord-350182-s10nong7	17	10	rodents	rodent	NNS
cord-350182-s10nong7	17	11	,	,	,
cord-350182-s10nong7	17	12	birds	bird	NNS
cord-350182-s10nong7	17	13	)	)	-RRB-
cord-350182-s10nong7	17	14	and	and	CC
cord-350182-s10nong7	17	15	can	can	MD
cord-350182-s10nong7	17	16	cross	cross	VB
cord-350182-s10nong7	17	17	barriers	barrier	NNS
cord-350182-s10nong7	17	18	between	between	IN
cord-350182-s10nong7	17	19	species	specie	NNS
cord-350182-s10nong7	17	20	,	,	,
cord-350182-s10nong7	17	21	also	also	RB
cord-350182-s10nong7	17	22	infecting	infect	VBG
cord-350182-s10nong7	17	23	humans	human	NNS
cord-350182-s10nong7	17	24	[	[	-LRB-
cord-350182-s10nong7	17	25	3	3	CD
cord-350182-s10nong7	17	26	]	]	-RRB-
cord-350182-s10nong7	17	27	.	.	.
cord-350182-s10nong7	18	1	The	the	DT
cord-350182-s10nong7	18	2	transmission	transmission	NN
cord-350182-s10nong7	18	3	of	of	IN
cord-350182-s10nong7	18	4	SARS	SARS	NNP
cord-350182-s10nong7	18	5	-	-	HYPH
cord-350182-s10nong7	18	6	CoV-2	CoV-2	NNP
cord-350182-s10nong7	18	7	among	among	IN
cord-350182-s10nong7	18	8	humans	human	NNS
cord-350182-s10nong7	18	9	occurs	occur	VBZ
cord-350182-s10nong7	18	10	mainly	mainly	RB
cord-350182-s10nong7	18	11	through	through	IN
cord-350182-s10nong7	18	12	direct	direct	JJ
cord-350182-s10nong7	18	13	contact	contact	NN
cord-350182-s10nong7	18	14	or	or	CC
cord-350182-s10nong7	18	15	droplets	droplet	NNS
cord-350182-s10nong7	18	16	spread	spread	VBN
cord-350182-s10nong7	18	17	by	by	IN
cord-350182-s10nong7	18	18	coughing	cough	VBG
cord-350182-s10nong7	18	19	or	or	CC
cord-350182-s10nong7	18	20	sneezing	sneeze	VBG
cord-350182-s10nong7	18	21	from	from	IN
cord-350182-s10nong7	18	22	an	an	DT
cord-350182-s10nong7	18	23	infected	infected	JJ
cord-350182-s10nong7	18	24	individual	individual	NN
cord-350182-s10nong7	18	25	[	[	-LRB-
cord-350182-s10nong7	18	26	4	4	CD
cord-350182-s10nong7	18	27	]	]	-RRB-
cord-350182-s10nong7	18	28	.	.	.
cord-350182-s10nong7	19	1	The	the	DT
cord-350182-s10nong7	19	2	incubation	incubation	NN
cord-350182-s10nong7	19	3	period	period	NN
cord-350182-s10nong7	19	4	in	in	IN
cord-350182-s10nong7	19	5	most	most	JJS
cord-350182-s10nong7	19	6	individuals	individual	NNS
cord-350182-s10nong7	19	7	varies	vary	VBZ
cord-350182-s10nong7	19	8	between	between	IN
cord-350182-s10nong7	19	9	2	2	CD
cord-350182-s10nong7	19	10	and	and	CC
cord-350182-s10nong7	19	11	14	14	CD
cord-350182-s10nong7	19	12	days	day	NNS
cord-350182-s10nong7	19	13	[	[	-LRB-
cord-350182-s10nong7	19	14	5	5	CD
cord-350182-s10nong7	19	15	]	]	-RRB-
cord-350182-s10nong7	19	16	.	.	.
cord-350182-s10nong7	20	1	On	on	IN
cord-350182-s10nong7	20	2	average	average	JJ
cord-350182-s10nong7	20	3	,	,	,
cord-350182-s10nong7	20	4	each	each	DT
cord-350182-s10nong7	20	5	person	person	NN
cord-350182-s10nong7	20	6	has	have	VBZ
cord-350182-s10nong7	20	7	the	the	DT
cord-350182-s10nong7	20	8	potential	potential	NN
cord-350182-s10nong7	20	9	to	to	TO
cord-350182-s10nong7	20	10	spread	spread	VB
cord-350182-s10nong7	20	11	the	the	DT
cord-350182-s10nong7	20	12	infection	infection	NN
cord-350182-s10nong7	20	13	to	to	IN
cord-350182-s10nong7	20	14	2.2	2.2	CD
cord-350182-s10nong7	20	15	-	-	SYM
cord-350182-s10nong7	20	16	2.7	2.7	CD
cord-350182-s10nong7	20	17	other	other	JJ
cord-350182-s10nong7	20	18	people	people	NNS
cord-350182-s10nong7	20	19	[	[	-LRB-
cord-350182-s10nong7	20	20	6	6	CD
cord-350182-s10nong7	20	21	]	]	-RRB-
cord-350182-s10nong7	20	22	.	.	.
cord-350182-s10nong7	21	1	The	the	DT
cord-350182-s10nong7	21	2	majority	majority	NN
cord-350182-s10nong7	21	3	of	of	IN
cord-350182-s10nong7	21	4	infected	infected	JJ
cord-350182-s10nong7	21	5	individuals	individual	NNS
cord-350182-s10nong7	21	6	(	(	-LRB-
cord-350182-s10nong7	21	7	about	about	RB
cord-350182-s10nong7	21	8	80	80	CD
cord-350182-s10nong7	21	9	%	%	NN
cord-350182-s10nong7	21	10	)	)	-RRB-
cord-350182-s10nong7	21	11	remains	remain	VBZ
cord-350182-s10nong7	21	12	asymptomatic	asymptomatic	JJ
cord-350182-s10nong7	21	13	or	or	CC
cord-350182-s10nong7	21	14	with	with	IN
cord-350182-s10nong7	21	15	mild	mild	JJ
cord-350182-s10nong7	21	16	symptoms	symptom	NNS
cord-350182-s10nong7	21	17	,	,	,
cord-350182-s10nong7	21	18	whilst	whilst	IN
cord-350182-s10nong7	21	19	the	the	DT
cord-350182-s10nong7	21	20	remainder	remainder	NN
cord-350182-s10nong7	21	21	suffer	suffer	VBP
cord-350182-s10nong7	21	22	from	from	IN
cord-350182-s10nong7	21	23	severe	severe	JJ
cord-350182-s10nong7	21	24	or	or	CC
cord-350182-s10nong7	21	25	critical	critical	JJ
cord-350182-s10nong7	21	26	clinical	clinical	JJ
cord-350182-s10nong7	21	27	features	feature	NNS
cord-350182-s10nong7	21	28	.	.	.
cord-350182-s10nong7	22	1	The	the	DT
cord-350182-s10nong7	22	2	most	most	RBS
cord-350182-s10nong7	22	3	common	common	JJ
cord-350182-s10nong7	22	4	symptoms	symptom	NNS
cord-350182-s10nong7	22	5	of	of	IN
cord-350182-s10nong7	22	6	COVID-19	covid-19	DT
cord-350182-s10nong7	22	7	include	include	VBP
cord-350182-s10nong7	22	8	fever	fever	NN
cord-350182-s10nong7	22	9	,	,	,
cord-350182-s10nong7	22	10	cough	cough	NN
cord-350182-s10nong7	22	11	,	,	,
cord-350182-s10nong7	22	12	sore	sore	JJ
cord-350182-s10nong7	22	13	throat	throat	NN
cord-350182-s10nong7	22	14	,	,	,
cord-350182-s10nong7	22	15	malaise	malaise	NN
cord-350182-s10nong7	22	16	and	and	CC
cord-350182-s10nong7	22	17	dyspnoea	dyspnoea	NNS
cord-350182-s10nong7	22	18	.	.	.
cord-350182-s10nong7	23	1	In	in	IN
cord-350182-s10nong7	23	2	severe	severe	JJ
cord-350182-s10nong7	23	3	cases	case	NNS
cord-350182-s10nong7	23	4	,	,	,
cord-350182-s10nong7	23	5	patients	patient	NNS
cord-350182-s10nong7	23	6	may	may	MD
cord-350182-s10nong7	23	7	develop	develop	VB
cord-350182-s10nong7	23	8	pneumonia	pneumonia	NN
cord-350182-s10nong7	23	9	,	,	,
cord-350182-s10nong7	23	10	acute	acute	JJ
cord-350182-s10nong7	23	11	respiratory	respiratory	JJ
cord-350182-s10nong7	23	12	distress	distress	NN
cord-350182-s10nong7	23	13	syndrome	syndrome	NN
cord-350182-s10nong7	23	14	,	,	,
cord-350182-s10nong7	23	15	respiratory	respiratory	JJ
cord-350182-s10nong7	23	16	failure	failure	NN
cord-350182-s10nong7	23	17	,	,	,
cord-350182-s10nong7	23	18	septic	septic	JJ
cord-350182-s10nong7	23	19	shock	shock	NN
cord-350182-s10nong7	23	20	and	and	CC
cord-350182-s10nong7	23	21	multi	multi	JJ
cord-350182-s10nong7	23	22	-	-	JJ
cord-350182-s10nong7	23	23	organ	organ	JJ
cord-350182-s10nong7	23	24	failure	failure	NN
cord-350182-s10nong7	23	25	which	which	WDT
cord-350182-s10nong7	23	26	can	can	MD
cord-350182-s10nong7	23	27	lead	lead	VB
cord-350182-s10nong7	23	28	to	to	IN
cord-350182-s10nong7	23	29	death	death	NN
cord-350182-s10nong7	23	30	[	[	-LRB-
cord-350182-s10nong7	23	31	7	7	CD
cord-350182-s10nong7	23	32	]	]	-RRB-
cord-350182-s10nong7	23	33	.	.	.
cord-350182-s10nong7	24	1	The	the	DT
cord-350182-s10nong7	24	2	elderly	elderly	JJ
cord-350182-s10nong7	24	3	and	and	CC
cord-350182-s10nong7	24	4	those	those	DT
cord-350182-s10nong7	24	5	with	with	IN
cord-350182-s10nong7	24	6	underlying	underlie	VBG
cord-350182-s10nong7	24	7	diseases	disease	NNS
cord-350182-s10nong7	24	8	(	(	-LRB-
cord-350182-s10nong7	24	9	such	such	JJ
cord-350182-s10nong7	24	10	as	as	IN
cord-350182-s10nong7	24	11	hypertension	hypertension	NN
cord-350182-s10nong7	24	12	,	,	,
cord-350182-s10nong7	24	13	cardiovascular	cardiovascular	JJ
cord-350182-s10nong7	24	14	diseases	disease	NNS
cord-350182-s10nong7	24	15	,	,	,
cord-350182-s10nong7	24	16	diabetes	diabete	VBZ
cord-350182-s10nong7	24	17	mellitus	mellitus	NN
cord-350182-s10nong7	24	18	and	and	CC
cord-350182-s10nong7	24	19	chronic	chronic	JJ
cord-350182-s10nong7	24	20	pulmonary	pulmonary	JJ
cord-350182-s10nong7	24	21	diseases	disease	NNS
cord-350182-s10nong7	24	22	)	)	-RRB-
cord-350182-s10nong7	24	23	are	be	VBP
cord-350182-s10nong7	24	24	more	more	JJR
cord-350182-s10nong7	24	25	at	at	IN
cord-350182-s10nong7	24	26	risk	risk	NN
cord-350182-s10nong7	24	27	of	of	IN
cord-350182-s10nong7	24	28	adverse	adverse	JJ
cord-350182-s10nong7	24	29	outcomes	outcome	NNS
cord-350182-s10nong7	24	30	[	[	-LRB-
cord-350182-s10nong7	24	31	8	8	CD
cord-350182-s10nong7	24	32	]	]	-RRB-
cord-350182-s10nong7	24	33	.	.	.
cord-350182-s10nong7	25	1	The	the	DT
cord-350182-s10nong7	25	2	first	first	JJ
cord-350182-s10nong7	25	3	cases	case	NNS
cord-350182-s10nong7	25	4	of	of	IN
cord-350182-s10nong7	25	5	COVID-19	COVID-19	,
cord-350182-s10nong7	25	6	were	be	VBD
cord-350182-s10nong7	25	7	detected	detect	VBN
cord-350182-s10nong7	25	8	in	in	IN
cord-350182-s10nong7	25	9	Wuhan	Wuhan	NNP
cord-350182-s10nong7	25	10	,	,	,
cord-350182-s10nong7	25	11	the	the	DT
cord-350182-s10nong7	25	12	largest	large	JJS
cord-350182-s10nong7	25	13	metropolitan	metropolitan	JJ
cord-350182-s10nong7	25	14	area	area	NN
cord-350182-s10nong7	25	15	in	in	IN
cord-350182-s10nong7	25	16	Hubei	Hubei	NNP
cord-350182-s10nong7	25	17	province	province	NN
cord-350182-s10nong7	25	18	,	,	,
cord-350182-s10nong7	25	19	China	China	NNP
cord-350182-s10nong7	25	20	.	.	.
cord-350182-s10nong7	26	1	The	the	DT
cord-350182-s10nong7	26	2	spread	spread	NN
cord-350182-s10nong7	26	3	of	of	IN
cord-350182-s10nong7	26	4	the	the	DT
cord-350182-s10nong7	26	5	disease	disease	NN
cord-350182-s10nong7	26	6	evolved	evolve	VBD
cord-350182-s10nong7	26	7	quickly	quickly	RB
cord-350182-s10nong7	26	8	to	to	IN
cord-350182-s10nong7	26	9	a	a	DT
cord-350182-s10nong7	26	10	pandemic	pandemic	NN
cord-350182-s10nong7	26	11	.	.	.
cord-350182-s10nong7	27	1	As	as	IN
cord-350182-s10nong7	27	2	of	of	IN
cord-350182-s10nong7	27	3	June	June	NNP
cord-350182-s10nong7	27	4	29	29	CD
cord-350182-s10nong7	27	5	,	,	,
cord-350182-s10nong7	27	6	2020	2020	CD
cord-350182-s10nong7	27	7	,	,	,
cord-350182-s10nong7	27	8	the	the	DT
cord-350182-s10nong7	27	9	number	number	NN
cord-350182-s10nong7	27	10	of	of	IN
cord-350182-s10nong7	27	11	COVID-19	covid-19	JJ
cord-350182-s10nong7	27	12	infections	infection	NNS
cord-350182-s10nong7	27	13	globally	globally	RB
cord-350182-s10nong7	27	14	has	have	VBZ
cord-350182-s10nong7	27	15	exceeded	exceed	VBN
cord-350182-s10nong7	27	16	10	10	CD
cord-350182-s10nong7	27	17	million	million	CD
cord-350182-s10nong7	27	18	cases	case	NNS
cord-350182-s10nong7	27	19	in	in	IN
cord-350182-s10nong7	27	20	188	188	CD
cord-350182-s10nong7	27	21	countries	country	NNS
cord-350182-s10nong7	27	22	/	/	SYM
cord-350182-s10nong7	27	23	regions	region	NNS
cord-350182-s10nong7	27	24	causing	cause	VBG
cord-350182-s10nong7	27	25	more	more	JJR
cord-350182-s10nong7	27	26	than	than	IN
cord-350182-s10nong7	27	27	500,000	500,000	CD
cord-350182-s10nong7	27	28	deaths	death	NNS
cord-350182-s10nong7	27	29	[	[	-LRB-
cord-350182-s10nong7	27	30	9	9	CD
cord-350182-s10nong7	27	31	]	]	-RRB-
cord-350182-s10nong7	27	32	.	.	.
cord-350182-s10nong7	28	1	Many	many	JJ
cord-350182-s10nong7	28	2	issues	issue	NNS
cord-350182-s10nong7	28	3	still	still	RB
cord-350182-s10nong7	28	4	remain	remain	VBP
cord-350182-s10nong7	28	5	to	to	TO
cord-350182-s10nong7	28	6	be	be	VB
cord-350182-s10nong7	28	7	determined	determine	VBN
cord-350182-s10nong7	28	8	with	with	IN
cord-350182-s10nong7	28	9	regard	regard	NN
cord-350182-s10nong7	28	10	to	to	IN
cord-350182-s10nong7	28	11	the	the	DT
cord-350182-s10nong7	28	12	epidemiological	epidemiological	JJ
cord-350182-s10nong7	28	13	evolution	evolution	NN
cord-350182-s10nong7	28	14	of	of	IN
cord-350182-s10nong7	28	15	the	the	DT
cord-350182-s10nong7	28	16	disease	disease	NN
cord-350182-s10nong7	28	17	,	,	,
cord-350182-s10nong7	28	18	especially	especially	RB
cord-350182-s10nong7	28	19	the	the	DT
cord-350182-s10nong7	28	20	de	de	NN
cord-350182-s10nong7	28	21	-	-	NN
cord-350182-s10nong7	28	22	escalation	escalation	NN
cord-350182-s10nong7	28	23	of	of	IN
cord-350182-s10nong7	28	24	its	-PRON-	PRP$
cord-350182-s10nong7	28	25	prevalence	prevalence	NN
cord-350182-s10nong7	28	26	,	,	,
cord-350182-s10nong7	28	27	possible	possible	JJ
cord-350182-s10nong7	28	28	seasonal	seasonal	JJ
cord-350182-s10nong7	28	29	fluctuations	fluctuation	NNS
cord-350182-s10nong7	28	30	of	of	IN
cord-350182-s10nong7	28	31	its	-PRON-	PRP$
cord-350182-s10nong7	28	32	incidence	incidence	NN
cord-350182-s10nong7	28	33	and	and	CC
cord-350182-s10nong7	28	34	the	the	DT
cord-350182-s10nong7	28	35	risk	risk	NN
cord-350182-s10nong7	28	36	for	for	IN
cord-350182-s10nong7	28	37	future	future	JJ
cord-350182-s10nong7	28	38	widespread	widespread	JJ
cord-350182-s10nong7	28	39	reoccurrences	reoccurrence	NNS
cord-350182-s10nong7	28	40	.	.	.
cord-350182-s10nong7	29	1	Nevertheless	nevertheless	RB
cord-350182-s10nong7	29	2	,	,	,
cord-350182-s10nong7	29	3	it	-PRON-	PRP
cord-350182-s10nong7	29	4	is	be	VBZ
cord-350182-s10nong7	29	5	already	already	RB
cord-350182-s10nong7	29	6	known	know	VBN
cord-350182-s10nong7	29	7	that	that	IN
cord-350182-s10nong7	29	8	the	the	DT
cord-350182-s10nong7	29	9	resulting	result	VBG
cord-350182-s10nong7	29	10	outbreak	outbreak	NN
cord-350182-s10nong7	29	11	of	of	IN
cord-350182-s10nong7	29	12	COVID-19	COVID-19	NNP
cord-350182-s10nong7	29	13	has	have	VBZ
cord-350182-s10nong7	29	14	had	have	VBN
cord-350182-s10nong7	29	15	a	a	DT
cord-350182-s10nong7	29	16	detrimental	detrimental	JJ
cord-350182-s10nong7	29	17	effect	effect	NN
cord-350182-s10nong7	29	18	on	on	IN
cord-350182-s10nong7	29	19	public	public	JJ
cord-350182-s10nong7	29	20	health	health	NN
cord-350182-s10nong7	29	21	,	,	,
cord-350182-s10nong7	29	22	causing	cause	VBG
cord-350182-s10nong7	29	23	numerous	numerous	JJ
cord-350182-s10nong7	29	24	deaths	death	NNS
cord-350182-s10nong7	29	25	and	and	CC
cord-350182-s10nong7	29	26	burdening	burden	VBG
cord-350182-s10nong7	29	27	tremendously	tremendously	RB
cord-350182-s10nong7	29	28	the	the	DT
cord-350182-s10nong7	29	29	health	health	NN
cord-350182-s10nong7	29	30	systems	system	NNS
cord-350182-s10nong7	29	31	worldwide	worldwide	RB
cord-350182-s10nong7	29	32	.	.	.
cord-350182-s10nong7	30	1	For	for	IN
cord-350182-s10nong7	30	2	this	this	DT
cord-350182-s10nong7	30	3	reason	reason	NN
cord-350182-s10nong7	30	4	,	,	,
cord-350182-s10nong7	30	5	states	state	NNS
cord-350182-s10nong7	30	6	around	around	IN
cord-350182-s10nong7	30	7	the	the	DT
cord-350182-s10nong7	30	8	world	world	NN
cord-350182-s10nong7	30	9	have	have	VBP
cord-350182-s10nong7	30	10	been	be	VBN
cord-350182-s10nong7	30	11	taking	take	VBG
cord-350182-s10nong7	30	12	measures	measure	NNS
cord-350182-s10nong7	30	13	to	to	TO
cord-350182-s10nong7	30	14	restrict	restrict	VB
cord-350182-s10nong7	30	15	the	the	DT
cord-350182-s10nong7	30	16	impact	impact	NN
cord-350182-s10nong7	30	17	of	of	IN
cord-350182-s10nong7	30	18	the	the	DT
cord-350182-s10nong7	30	19	spread	spread	NN
cord-350182-s10nong7	30	20	.	.	.
cord-350182-s10nong7	31	1	At	at	IN
cord-350182-s10nong7	31	2	the	the	DT
cord-350182-s10nong7	31	3	moment	moment	NN
cord-350182-s10nong7	31	4	,	,	,
cord-350182-s10nong7	31	5	management	management	NN
cord-350182-s10nong7	31	6	strategies	strategy	NNS
cord-350182-s10nong7	31	7	aim	aim	VBP
cord-350182-s10nong7	31	8	at	at	IN
cord-350182-s10nong7	31	9	reducing	reduce	VBG
cord-350182-s10nong7	31	10	transmission	transmission	NN
cord-350182-s10nong7	31	11	in	in	IN
cord-350182-s10nong7	31	12	the	the	DT
cord-350182-s10nong7	31	13	community	community	NN
cord-350182-s10nong7	31	14	and	and	CC
cord-350182-s10nong7	31	15	supporting	support	VBG
cord-350182-s10nong7	31	16	patients	patient	NNS
cord-350182-s10nong7	31	17	with	with	IN
cord-350182-s10nong7	31	18	severe	severe	JJ
cord-350182-s10nong7	31	19	clinical	clinical	JJ
cord-350182-s10nong7	31	20	features	feature	NNS
cord-350182-s10nong7	31	21	.	.	.
cord-350182-s10nong7	32	1	At	at	IN
cord-350182-s10nong7	32	2	the	the	DT
cord-350182-s10nong7	32	3	same	same	JJ
cord-350182-s10nong7	32	4	time	time	NN
cord-350182-s10nong7	32	5	,	,	,
cord-350182-s10nong7	32	6	researchers	researcher	NNS
cord-350182-s10nong7	32	7	have	have	VBP
cord-350182-s10nong7	32	8	been	be	VBN
cord-350182-s10nong7	32	9	working	work	VBG
cord-350182-s10nong7	32	10	intensively	intensively	RB
cord-350182-s10nong7	32	11	towards	towards	IN
cord-350182-s10nong7	32	12	the	the	DT
cord-350182-s10nong7	32	13	establishment	establishment	NN
cord-350182-s10nong7	32	14	of	of	IN
cord-350182-s10nong7	32	15	novel	novel	JJ
cord-350182-s10nong7	32	16	diagnostic	diagnostic	JJ
cord-350182-s10nong7	32	17	procedures	procedure	NNS
cord-350182-s10nong7	32	18	,	,	,
cord-350182-s10nong7	32	19	effective	effective	JJ
cord-350182-s10nong7	32	20	therapeutic	therapeutic	JJ
cord-350182-s10nong7	32	21	regimens	regimen	NNS
cord-350182-s10nong7	32	22	and	and	CC
cord-350182-s10nong7	32	23	prevention	prevention	NN
cord-350182-s10nong7	32	24	products	product	NNS
cord-350182-s10nong7	32	25	.	.	.
cord-350182-s10nong7	33	1	Coronaviruses	coronaviruse	NNS
cord-350182-s10nong7	33	2	'	'	POS
cord-350182-s10nong7	33	3	entry	entry	NN
cord-350182-s10nong7	33	4	into	into	IN
cord-350182-s10nong7	33	5	susceptible	susceptible	JJ
cord-350182-s10nong7	33	6	cells	cell	NNS
cord-350182-s10nong7	33	7	is	be	VBZ
cord-350182-s10nong7	33	8	a	a	DT
cord-350182-s10nong7	33	9	complex	complex	JJ
cord-350182-s10nong7	33	10	process	process	NN
cord-350182-s10nong7	33	11	that	that	WDT
cord-350182-s10nong7	33	12	is	be	VBZ
cord-350182-s10nong7	33	13	mediated	mediate	VBN
cord-350182-s10nong7	33	14	through	through	IN
cord-350182-s10nong7	33	15	binding	binding	NN
cord-350182-s10nong7	33	16	of	of	IN
cord-350182-s10nong7	33	17	the	the	DT
cord-350182-s10nong7	33	18	viral	viral	JJ
cord-350182-s10nong7	33	19	surfaceexposed	surfaceexposed	JJ
cord-350182-s10nong7	33	20	spike	spike	NN
cord-350182-s10nong7	33	21	(	(	-LRB-
cord-350182-s10nong7	33	22	S	s	NN
cord-350182-s10nong7	33	23	)	)	-RRB-
cord-350182-s10nong7	33	24	glycoprotein	glycoprotein	NN
cord-350182-s10nong7	33	25	to	to	IN
cord-350182-s10nong7	33	26	the	the	DT
cord-350182-s10nong7	33	27	host	host	NN
cord-350182-s10nong7	33	28	cell	cell	NN
cord-350182-s10nong7	33	29	receptor	receptor	NN
cord-350182-s10nong7	33	30	.	.	.
cord-350182-s10nong7	34	1	This	this	DT
cord-350182-s10nong7	34	2	interaction	interaction	NN
cord-350182-s10nong7	34	3	promotes	promote	VBZ
cord-350182-s10nong7	34	4	the	the	DT
cord-350182-s10nong7	34	5	fusion	fusion	NN
cord-350182-s10nong7	34	6	of	of	IN
cord-350182-s10nong7	34	7	the	the	DT
cord-350182-s10nong7	34	8	viral	viral	JJ
cord-350182-s10nong7	34	9	and	and	CC
cord-350182-s10nong7	34	10	cellular	cellular	JJ
cord-350182-s10nong7	34	11	membranes	membrane	NNS
cord-350182-s10nong7	34	12	.	.	.
cord-350182-s10nong7	35	1	SARS	SARS	NNP
cord-350182-s10nong7	35	2	-	-	HYPH
cord-350182-s10nong7	35	3	related	relate	VBN
cord-350182-s10nong7	35	4	coronaviruses	coronaviruse	NNS
cord-350182-s10nong7	35	5	interact	interact	VBP
cord-350182-s10nong7	35	6	directly	directly	RB
cord-350182-s10nong7	35	7	with	with	IN
cord-350182-s10nong7	35	8	angiotensin	angiotensin	NN
cord-350182-s10nong7	35	9	-	-	HYPH
cord-350182-s10nong7	35	10	converting	convert	VBG
cord-350182-s10nong7	35	11	enzyme	enzyme	NN
cord-350182-s10nong7	35	12	2	2	CD
cord-350182-s10nong7	35	13	(	(	-LRB-
cord-350182-s10nong7	35	14	ACE2	ACE2	NNP
cord-350182-s10nong7	35	15	)	)	-RRB-
cord-350182-s10nong7	35	16	via	via	IN
cord-350182-s10nong7	35	17	the	the	DT
cord-350182-s10nong7	35	18	domain	domain	NN
cord-350182-s10nong7	35	19	B	b	NN
cord-350182-s10nong7	35	20	of	of	IN
cord-350182-s10nong7	35	21	the	the	DT
cord-350182-s10nong7	35	22	S	S	NNP
cord-350182-s10nong7	35	23	glycoprotein	glycoprotein	NN
cord-350182-s10nong7	35	24	to	to	TO
cord-350182-s10nong7	35	25	enter	enter	VB
cord-350182-s10nong7	35	26	cells	cell	NNS
cord-350182-s10nong7	35	27	[	[	-LRB-
cord-350182-s10nong7	35	28	10	10	CD
cord-350182-s10nong7	35	29	]	]	-RRB-
cord-350182-s10nong7	35	30	.	.	.
cord-350182-s10nong7	36	1	ACE2	ACE2	NNP
cord-350182-s10nong7	36	2	is	be	VBZ
cord-350182-s10nong7	36	3	mainly	mainly	RB
cord-350182-s10nong7	36	4	expressed	express	VBN
cord-350182-s10nong7	36	5	in	in	IN
cord-350182-s10nong7	36	6	type	type	NN
cord-350182-s10nong7	36	7	2	2	CD
cord-350182-s10nong7	36	8	alveolar	alveolar	NN
cord-350182-s10nong7	36	9	cells	cell	NNS
cord-350182-s10nong7	36	10	in	in	IN
cord-350182-s10nong7	36	11	the	the	DT
cord-350182-s10nong7	36	12	lungs	lung	NNS
cord-350182-s10nong7	36	13	[	[	-LRB-
cord-350182-s10nong7	36	14	11	11	CD
cord-350182-s10nong7	36	15	]	]	-RRB-
cord-350182-s10nong7	36	16	.	.	.
cord-350182-s10nong7	37	1	The	the	DT
cord-350182-s10nong7	37	2	first	first	JJ
cord-350182-s10nong7	37	3	-	-	HYPH
cord-350182-s10nong7	37	4	line	line	NN
cord-350182-s10nong7	37	5	defence	defence	NN
cord-350182-s10nong7	37	6	against	against	IN
cord-350182-s10nong7	37	7	viral	viral	JJ
cord-350182-s10nong7	37	8	infection	infection	NN
cord-350182-s10nong7	37	9	is	be	VBZ
cord-350182-s10nong7	37	10	the	the	DT
cord-350182-s10nong7	37	11	production	production	NN
cord-350182-s10nong7	37	12	of	of	IN
cord-350182-s10nong7	37	13	type	type	NN
cord-350182-s10nong7	37	14	I	-PRON-	PRP
cord-350182-s10nong7	37	15	interferons	interferon	NNS
cord-350182-s10nong7	37	16	(	(	-LRB-
cord-350182-s10nong7	37	17	IFNs	ifns	NN
cord-350182-s10nong7	37	18	-	-	HYPH
cord-350182-s10nong7	37	19	α	α	NN
cord-350182-s10nong7	37	20	/	/	SYM
cord-350182-s10nong7	37	21	β	β	NN
cord-350182-s10nong7	37	22	)	)	-RRB-
cord-350182-s10nong7	37	23	which	which	WDT
cord-350182-s10nong7	37	24	is	be	VBZ
cord-350182-s10nong7	37	25	an	an	DT
cord-350182-s10nong7	37	26	essential	essential	JJ
cord-350182-s10nong7	37	27	part	part	NN
cord-350182-s10nong7	37	28	of	of	IN
cord-350182-s10nong7	37	29	the	the	DT
cord-350182-s10nong7	37	30	innate	innate	JJ
cord-350182-s10nong7	37	31	immune	immune	JJ
cord-350182-s10nong7	37	32	system	system	NN
cord-350182-s10nong7	37	33	.	.	.
cord-350182-s10nong7	38	1	In	in	IN
cord-350182-s10nong7	38	2	RNA	RNA	NNP
cord-350182-s10nong7	38	3	viruses	virus	NNS
cord-350182-s10nong7	38	4	,	,	,
cord-350182-s10nong7	38	5	such	such	JJ
cord-350182-s10nong7	38	6	as	as	IN
cord-350182-s10nong7	38	7	the	the	DT
cord-350182-s10nong7	38	8	coronaviruses	coronaviruse	NNS
cord-350182-s10nong7	38	9	,	,	,
cord-350182-s10nong7	38	10	the	the	DT
cord-350182-s10nong7	38	11	viral	viral	JJ
cord-350182-s10nong7	38	12	genome	genome	NN
cord-350182-s10nong7	38	13	or	or	CC
cord-350182-s10nong7	38	14	the	the	DT
cord-350182-s10nong7	38	15	intermediates	intermediate	NNS
cord-350182-s10nong7	38	16	during	during	IN
cord-350182-s10nong7	38	17	viral	viral	JJ
cord-350182-s10nong7	38	18	replication	replication	NN
cord-350182-s10nong7	38	19	are	be	VBP
cord-350182-s10nong7	38	20	recognised	recognise	VBN
cord-350182-s10nong7	38	21	by	by	IN
cord-350182-s10nong7	38	22	either	either	CC
cord-350182-s10nong7	38	23	endosomal	endosomal	NNP
cord-350182-s10nong7	38	24	RNA	RNA	NNP
cord-350182-s10nong7	38	25	receptors	receptor	NNS
cord-350182-s10nong7	38	26	or	or	CC
cord-350182-s10nong7	38	27	cytosolic	cytosolic	JJ
cord-350182-s10nong7	38	28	RNA	RNA	NNP
cord-350182-s10nong7	38	29	sensors	sensor	NNS
cord-350182-s10nong7	38	30	in	in	IN
cord-350182-s10nong7	38	31	all	all	DT
cord-350182-s10nong7	38	32	nucleated	nucleated	JJ
cord-350182-s10nong7	38	33	cells	cell	NNS
cord-350182-s10nong7	38	34	of	of	IN
cord-350182-s10nong7	38	35	mammalians	mammalian	NNS
cord-350182-s10nong7	38	36	.	.	.
cord-350182-s10nong7	39	1	This	this	DT
cord-350182-s10nong7	39	2	interaction	interaction	NN
cord-350182-s10nong7	39	3	leads	lead	VBZ
cord-350182-s10nong7	39	4	to	to	IN
cord-350182-s10nong7	39	5	a	a	DT
cord-350182-s10nong7	39	6	downstream	downstream	JJ
cord-350182-s10nong7	39	7	signalling	signal	VBG
cord-350182-s10nong7	39	8	cascade	cascade	NN
cord-350182-s10nong7	39	9	and	and	CC
cord-350182-s10nong7	39	10	an	an	DT
cord-350182-s10nong7	39	11	accompanying	accompany	VBG
cord-350182-s10nong7	39	12	translocation	translocation	NN
cord-350182-s10nong7	39	13	of	of	IN
cord-350182-s10nong7	39	14	nuclear	nuclear	JJ
cord-350182-s10nong7	39	15	factors	factor	NNS
cord-350182-s10nong7	39	16	.	.	.
cord-350182-s10nong7	40	1	This	this	DT
cord-350182-s10nong7	40	2	process	process	NN
cord-350182-s10nong7	40	3	results	result	VBZ
cord-350182-s10nong7	40	4	in	in	IN
cord-350182-s10nong7	40	5	expression	expression	NN
cord-350182-s10nong7	40	6	of	of	IN
cord-350182-s10nong7	40	7	IFNs	ifn	NNS
cord-350182-s10nong7	40	8	-	-	HYPH
cord-350182-s10nong7	40	9	α	α	NNP
cord-350182-s10nong7	40	10	/	/	SYM
cord-350182-s10nong7	40	11	β	β	NN
cord-350182-s10nong7	40	12	and	and	CC
cord-350182-s10nong7	40	13	other	other	JJ
cord-350182-s10nong7	40	14	pro	pro	JJ
cord-350182-s10nong7	40	15	-	-	JJ
cord-350182-s10nong7	40	16	inflammatory	inflammatory	JJ
cord-350182-s10nong7	40	17	cytokines	cytokine	NNS
cord-350182-s10nong7	40	18	.	.	.
cord-350182-s10nong7	41	1	These	these	DT
cord-350182-s10nong7	41	2	interferons	interferon	NNS
cord-350182-s10nong7	41	3	act	act	VBP
cord-350182-s10nong7	41	4	to	to	IN
cord-350182-s10nong7	41	5	neighbouring	neighbouring	NN
cord-350182-s10nong7	41	6	cells	cell	NNS
cord-350182-s10nong7	41	7	and	and	CC
cord-350182-s10nong7	41	8	via	via	IN
cord-350182-s10nong7	41	9	the	the	DT
cord-350182-s10nong7	41	10	JAK	JAK	NNP
cord-350182-s10nong7	41	11	-	-	HYPH
cord-350182-s10nong7	41	12	STAT	STAT	NNP
cord-350182-s10nong7	41	13	pathway	pathway	NN
cord-350182-s10nong7	41	14	stimulate	stimulate	VBP
cord-350182-s10nong7	41	15	the	the	DT
cord-350182-s10nong7	41	16	expression	expression	NN
cord-350182-s10nong7	41	17	of	of	IN
cord-350182-s10nong7	41	18	antiviral	antiviral	JJ
cord-350182-s10nong7	41	19	proteins	protein	NNS
cord-350182-s10nong7	41	20	and	and	CC
cord-350182-s10nong7	41	21	induce	induce	VB
cord-350182-s10nong7	41	22	other	other	JJ
cord-350182-s10nong7	41	23	biological	biological	JJ
cord-350182-s10nong7	41	24	activities	activity	NNS
cord-350182-s10nong7	41	25	such	such	JJ
cord-350182-s10nong7	41	26	as	as	IN
cord-350182-s10nong7	41	27	inhibition	inhibition	NN
cord-350182-s10nong7	41	28	of	of	IN
cord-350182-s10nong7	41	29	cell	cell	NN
cord-350182-s10nong7	41	30	proliferation	proliferation	NN
cord-350182-s10nong7	41	31	,	,	,
cord-350182-s10nong7	41	32	regulation	regulation	NN
cord-350182-s10nong7	41	33	of	of	IN
cord-350182-s10nong7	41	34	apoptosis	apoptosis	NN
cord-350182-s10nong7	41	35	and	and	CC
cord-350182-s10nong7	41	36	immunomodulation	immunomodulation	NN
cord-350182-s10nong7	41	37	[	[	-LRB-
cord-350182-s10nong7	41	38	12	12	CD
cord-350182-s10nong7	41	39	]	]	-RRB-
cord-350182-s10nong7	41	40	.	.	.
cord-350182-s10nong7	42	1	A	a	DT
cord-350182-s10nong7	42	2	successful	successful	JJ
cord-350182-s10nong7	42	3	response	response	NN
cord-350182-s10nong7	42	4	of	of	IN
cord-350182-s10nong7	42	5	the	the	DT
cord-350182-s10nong7	42	6	IFNs	ifns	NN
cord-350182-s10nong7	42	7	-	-	HYPH
cord-350182-s10nong7	42	8	α	α	NN
cord-350182-s10nong7	42	9	/	/	SYM
cord-350182-s10nong7	42	10	β	β	NN
cord-350182-s10nong7	42	11	-	-	HYPH
cord-350182-s10nong7	42	12	related	relate	VBN
cord-350182-s10nong7	42	13	innate	innate	JJ
cord-350182-s10nong7	42	14	immune	immune	JJ
cord-350182-s10nong7	42	15	system	system	NN
cord-350182-s10nong7	42	16	should	should	MD
cord-350182-s10nong7	42	17	be	be	VB
cord-350182-s10nong7	42	18	able	able	JJ
cord-350182-s10nong7	42	19	to	to	TO
cord-350182-s10nong7	42	20	control	control	VB
cord-350182-s10nong7	42	21	viral	viral	JJ
cord-350182-s10nong7	42	22	replication	replication	NN
cord-350182-s10nong7	42	23	and	and	CC
cord-350182-s10nong7	42	24	dispersion	dispersion	NN
cord-350182-s10nong7	42	25	in	in	IN
cord-350182-s10nong7	42	26	the	the	DT
cord-350182-s10nong7	42	27	body	body	NN
cord-350182-s10nong7	42	28	at	at	IN
cord-350182-s10nong7	42	29	an	an	DT
cord-350182-s10nong7	42	30	early	early	JJ
cord-350182-s10nong7	42	31	stage	stage	NN
cord-350182-s10nong7	42	32	,	,	,
cord-350182-s10nong7	42	33	at	at	IN
cord-350182-s10nong7	42	34	least	least	JJS
cord-350182-s10nong7	42	35	to	to	IN
cord-350182-s10nong7	42	36	an	an	DT
cord-350182-s10nong7	42	37	extent	extent	NN
cord-350182-s10nong7	42	38	.	.	.
cord-350182-s10nong7	43	1	However	however	RB
cord-350182-s10nong7	43	2	,	,	,
cord-350182-s10nong7	43	3	it	-PRON-	PRP
cord-350182-s10nong7	43	4	is	be	VBZ
cord-350182-s10nong7	43	5	believed	believe	VBN
cord-350182-s10nong7	43	6	that	that	IN
cord-350182-s10nong7	43	7	SARS	SARS	NNP
cord-350182-s10nong7	43	8	CoV-2	CoV-2	NNP
cord-350182-s10nong7	43	9	is	be	VBZ
cord-350182-s10nong7	43	10	able	able	JJ
cord-350182-s10nong7	43	11	to	to	TO
cord-350182-s10nong7	43	12	subvert	subvert	VB
cord-350182-s10nong7	43	13	the	the	DT
cord-350182-s10nong7	43	14	host	host	NN
cord-350182-s10nong7	43	15	response	response	NN
cord-350182-s10nong7	43	16	through	through	IN
cord-350182-s10nong7	43	17	the	the	DT
cord-350182-s10nong7	43	18	action	action	NN
cord-350182-s10nong7	43	19	of	of	IN
cord-350182-s10nong7	43	20	structural	structural	JJ
cord-350182-s10nong7	43	21	and	and	CC
cord-350182-s10nong7	43	22	nonstructural	nonstructural	JJ
cord-350182-s10nong7	43	23	proteins	protein	NNS
cord-350182-s10nong7	43	24	.	.	.
cord-350182-s10nong7	44	1	Due	due	IN
cord-350182-s10nong7	44	2	to	to	IN
cord-350182-s10nong7	44	3	the	the	DT
cord-350182-s10nong7	44	4	genomic	genomic	JJ
cord-350182-s10nong7	44	5	sequence	sequence	NN
cord-350182-s10nong7	44	6	similarities	similarity	NNS
cord-350182-s10nong7	44	7	with	with	IN
cord-350182-s10nong7	44	8	SARS	SARS	NNP
cord-350182-s10nong7	44	9	-	-	HYPH
cord-350182-s10nong7	44	10	CoV	CoV	NNP
cord-350182-s10nong7	44	11	(	(	-LRB-
cord-350182-s10nong7	44	12	and	and	CC
cord-350182-s10nong7	44	13	secondarily	secondarily	RB
cord-350182-s10nong7	44	14	with	with	IN
cord-350182-s10nong7	44	15	MERS	MERS	NNP
cord-350182-s10nong7	44	16	-	-	HYPH
cord-350182-s10nong7	44	17	CoV	CoV	NNP
cord-350182-s10nong7	44	18	)	)	-RRB-
cord-350182-s10nong7	44	19	,	,	,
cord-350182-s10nong7	44	20	it	-PRON-	PRP
cord-350182-s10nong7	44	21	is	be	VBZ
cord-350182-s10nong7	44	22	assumed	assume	VBN
cord-350182-s10nong7	44	23	that	that	IN
cord-350182-s10nong7	44	24	SARS	SARS	NNP
cord-350182-s10nong7	44	25	-	-	HYPH
cord-350182-s10nong7	44	26	CoV-2	CoV-2	NNP
cord-350182-s10nong7	44	27	interferes	interfere	VBZ
cord-350182-s10nong7	44	28	with	with	IN
cord-350182-s10nong7	44	29	the	the	DT
cord-350182-s10nong7	44	30	relevant	relevant	JJ
cord-350182-s10nong7	44	31	signalling	signalling	NN
cord-350182-s10nong7	44	32	processes	process	NNS
cord-350182-s10nong7	44	33	of	of	IN
cord-350182-s10nong7	44	34	the	the	DT
cord-350182-s10nong7	44	35	host	host	NN
cord-350182-s10nong7	44	36	cells	cell	NNS
cord-350182-s10nong7	44	37	through	through	IN
cord-350182-s10nong7	44	38	degradation	degradation	NN
cord-350182-s10nong7	44	39	or	or	CC
cord-350182-s10nong7	44	40	inhibition	inhibition	NN
cord-350182-s10nong7	44	41	of	of	IN
cord-350182-s10nong7	44	42	involved	involve	VBN
cord-350182-s10nong7	44	43	cellular	cellular	JJ
cord-350182-s10nong7	44	44	molecules	molecule	NNS
cord-350182-s10nong7	44	45	.	.	.
cord-350182-s10nong7	45	1	Consequently	consequently	RB
cord-350182-s10nong7	45	2	,	,	,
cord-350182-s10nong7	45	3	the	the	DT
cord-350182-s10nong7	45	4	delayed	delayed	JJ
cord-350182-s10nong7	45	5	or	or	CC
cord-350182-s10nong7	45	6	vitiated	vitiate	VBN
cord-350182-s10nong7	45	7	INFs	inf	NNS
cord-350182-s10nong7	45	8	-	-	HYPH
cord-350182-s10nong7	45	9	α	α	NNP
cord-350182-s10nong7	45	10	/	/	SYM
cord-350182-s10nong7	45	11	β	β	NN
cord-350182-s10nong7	45	12	response	response	NN
cord-350182-s10nong7	45	13	compromises	compromise	VBZ
cord-350182-s10nong7	45	14	the	the	DT
cord-350182-s10nong7	45	15	early	early	JJ
cord-350182-s10nong7	45	16	viral	viral	JJ
cord-350182-s10nong7	45	17	control	control	NN
cord-350182-s10nong7	45	18	,	,	,
cord-350182-s10nong7	45	19	leading	lead	VBG
cord-350182-s10nong7	45	20	to	to	IN
cord-350182-s10nong7	45	21	escalation	escalation	NN
cord-350182-s10nong7	45	22	of	of	IN
cord-350182-s10nong7	45	23	the	the	DT
cord-350182-s10nong7	45	24	concentration	concentration	NN
cord-350182-s10nong7	45	25	of	of	IN
cord-350182-s10nong7	45	26	inflammatory	inflammatory	JJ
cord-350182-s10nong7	45	27	neutrophils	neutrophil	NNS
cord-350182-s10nong7	45	28	and	and	CC
cord-350182-s10nong7	45	29	monocytes	monocyte	NNS
cord-350182-s10nong7	45	30	and	and	CC
cord-350182-s10nong7	45	31	in	in	IN
cord-350182-s10nong7	45	32	turn	turn	NN
cord-350182-s10nong7	45	33	to	to	IN
cord-350182-s10nong7	45	34	overproduction	overproduction	NN
cord-350182-s10nong7	45	35	of	of	IN
cord-350182-s10nong7	45	36	pro	pro	JJ
cord-350182-s10nong7	45	37	-	-	JJ
cord-350182-s10nong7	45	38	inflammatory	inflammatory	JJ
cord-350182-s10nong7	45	39	cytokines	cytokine	NNS
cord-350182-s10nong7	45	40	(	(	-LRB-
cord-350182-s10nong7	45	41	'	'	``
cord-350182-s10nong7	45	42	cytokine	cytokine	NN
cord-350182-s10nong7	45	43	storm	storm	NN
cord-350182-s10nong7	45	44	'	'	''
cord-350182-s10nong7	45	45	)	)	-RRB-
cord-350182-s10nong7	45	46	that	that	WDT
cord-350182-s10nong7	45	47	manifest	manifest	VBP
cord-350182-s10nong7	45	48	the	the	DT
cord-350182-s10nong7	45	49	lung	lung	NN
cord-350182-s10nong7	45	50	immunopathology	immunopathology	NN
cord-350182-s10nong7	45	51	of	of	IN
cord-350182-s10nong7	45	52	COVID-19	COVID-19	NNP
cord-350182-s10nong7	45	53	[	[	-LRB-
cord-350182-s10nong7	45	54	13	13	CD
cord-350182-s10nong7	45	55	]	]	-RRB-
cord-350182-s10nong7	45	56	.	.	.
cord-350182-s10nong7	46	1	The	the	DT
cord-350182-s10nong7	46	2	adaptive	adaptive	JJ
cord-350182-s10nong7	46	3	immunity	immunity	NN
cord-350182-s10nong7	46	4	response	response	NN
cord-350182-s10nong7	46	5	to	to	IN
cord-350182-s10nong7	46	6	SARS	SARS	NNP
cord-350182-s10nong7	46	7	-	-	HYPH
cord-350182-s10nong7	46	8	CoV-2	CoV-2	NNP
cord-350182-s10nong7	46	9	has	have	VBZ
cord-350182-s10nong7	46	10	not	not	RB
cord-350182-s10nong7	46	11	yet	yet	RB
cord-350182-s10nong7	46	12	been	be	VBN
cord-350182-s10nong7	46	13	clarified	clarify	VBN
cord-350182-s10nong7	46	14	.	.	.
cord-350182-s10nong7	47	1	Presumably	presumably	RB
cord-350182-s10nong7	47	2	,	,	,
cord-350182-s10nong7	47	3	antigens	antigen	NNS
cord-350182-s10nong7	47	4	from	from	IN
cord-350182-s10nong7	47	5	invading	invade	VBG
cord-350182-s10nong7	47	6	pathogens	pathogen	NNS
cord-350182-s10nong7	47	7	(	(	-LRB-
cord-350182-s10nong7	47	8	most	most	RBS
cord-350182-s10nong7	47	9	probably	probably	RB
cord-350182-s10nong7	47	10	the	the	DT
cord-350182-s10nong7	47	11	surface	surface	NN
cord-350182-s10nong7	47	12	-	-	HYPH
cord-350182-s10nong7	47	13	exposed	expose	VBN
cord-350182-s10nong7	47	14	spike	spike	NN
cord-350182-s10nong7	47	15	glycoprotein	glycoprotein	NN
cord-350182-s10nong7	47	16	but	but	CC
cord-350182-s10nong7	47	17	perhaps	perhaps	RB
cord-350182-s10nong7	47	18	also	also	RB
cord-350182-s10nong7	47	19	the	the	DT
cord-350182-s10nong7	47	20	membrane	membrane	NN
cord-350182-s10nong7	47	21	protein	protein	NN
cord-350182-s10nong7	47	22	)	)	-RRB-
cord-350182-s10nong7	47	23	are	be	VBP
cord-350182-s10nong7	47	24	acquired	acquire	VBN
cord-350182-s10nong7	47	25	by	by	IN
cord-350182-s10nong7	47	26	respiratory	respiratory	JJ
cord-350182-s10nong7	47	27	dendritic	dendritic	JJ
cord-350182-s10nong7	47	28	cells	cell	NNS
cord-350182-s10nong7	47	29	which	which	WDT
cord-350182-s10nong7	47	30	become	become	VBP
cord-350182-s10nong7	47	31	activated	activate	VBN
cord-350182-s10nong7	47	32	and	and	CC
cord-350182-s10nong7	47	33	present	present	VB
cord-350182-s10nong7	47	34	the	the	DT
cord-350182-s10nong7	47	35	processed	process	VBN
cord-350182-s10nong7	47	36	antigen	antigen	NN
cord-350182-s10nong7	47	37	to	to	IN
cord-350182-s10nong7	47	38	circulating	circulate	VBG
cord-350182-s10nong7	47	39	T	t	NN
cord-350182-s10nong7	47	40	cells	cell	NNS
cord-350182-s10nong7	47	41	.	.	.
cord-350182-s10nong7	48	1	Activated	Activated	NNP
cord-350182-s10nong7	48	2	CD4	CD4	NNP
cord-350182-s10nong7	48	3	+	+	CC
cord-350182-s10nong7	48	4	T	t	NN
cord-350182-s10nong7	48	5	cells	cell	NNS
cord-350182-s10nong7	48	6	promote	promote	VBP
cord-350182-s10nong7	48	7	the	the	DT
cord-350182-s10nong7	48	8	production	production	NN
cord-350182-s10nong7	48	9	of	of	IN
cord-350182-s10nong7	48	10	virus	virus	NN
cord-350182-s10nong7	48	11	-	-	HYPH
cord-350182-s10nong7	48	12	specific	specific	JJ
cord-350182-s10nong7	48	13	antibodies	antibody	NNS
cord-350182-s10nong7	48	14	by	by	IN
cord-350182-s10nong7	48	15	activating	activate	VBG
cord-350182-s10nong7	48	16	T	T	NNP
cord-350182-s10nong7	48	17	-	-	HYPH
cord-350182-s10nong7	48	18	dependent	dependent	JJ
cord-350182-s10nong7	48	19	B	b	NN
cord-350182-s10nong7	48	20	cells	cell	NNS
cord-350182-s10nong7	48	21	,	,	,
cord-350182-s10nong7	48	22	whilst	whilst	IN
cord-350182-s10nong7	48	23	CD8	CD8	NNP
cord-350182-s10nong7	48	24	+	+	CC
cord-350182-s10nong7	48	25	T	T	NNP
cord-350182-s10nong7	48	26	cells	cell	NNS
cord-350182-s10nong7	48	27	are	be	VBP
cord-350182-s10nong7	48	28	cytotoxic	cytotoxic	JJ
cord-350182-s10nong7	48	29	and	and	CC
cord-350182-s10nong7	48	30	can	can	MD
cord-350182-s10nong7	48	31	kill	kill	VB
cord-350182-s10nong7	48	32	infected	infected	JJ
cord-350182-s10nong7	48	33	cells	cell	NNS
cord-350182-s10nong7	48	34	.	.	.
cord-350182-s10nong7	49	1	In	in	IN
cord-350182-s10nong7	49	2	addition	addition	NN
cord-350182-s10nong7	49	3	,	,	,
cord-350182-s10nong7	49	4	B	b	NN
cord-350182-s10nong7	49	5	cells	cell	NNS
cord-350182-s10nong7	49	6	produce	produce	VBP
cord-350182-s10nong7	49	7	specific	specific	JJ
cord-350182-s10nong7	49	8	antibodies	antibody	NNS
cord-350182-s10nong7	49	9	which	which	WDT
cord-350182-s10nong7	49	10	may	may	MD
cord-350182-s10nong7	49	11	neutralise	neutralise	VB
cord-350182-s10nong7	49	12	the	the	DT
cord-350182-s10nong7	49	13	invading	invade	VBG
cord-350182-s10nong7	49	14	viruses	virus	NNS
cord-350182-s10nong7	49	15	[	[	-LRB-
cord-350182-s10nong7	49	16	14	14	CD
cord-350182-s10nong7	49	17	]	]	-RRB-
cord-350182-s10nong7	49	18	.	.	.
cord-350182-s10nong7	50	1	If	if	IN
cord-350182-s10nong7	50	2	the	the	DT
cord-350182-s10nong7	50	3	pathogenesis	pathogenesis	NN
cord-350182-s10nong7	50	4	in	in	IN
cord-350182-s10nong7	50	5	SARS	SARS	NNP
cord-350182-s10nong7	50	6	applies	apply	VBZ
cord-350182-s10nong7	50	7	to	to	IN
cord-350182-s10nong7	50	8	COVID-19	covid-19	VB
cord-350182-s10nong7	50	9	,	,	,
cord-350182-s10nong7	50	10	the	the	DT
cord-350182-s10nong7	50	11	upregulation	upregulation	NN
cord-350182-s10nong7	50	12	of	of	IN
cord-350182-s10nong7	50	13	pro	pro	JJ
cord-350182-s10nong7	50	14	-	-	JJ
cord-350182-s10nong7	50	15	inflammatory	inflammatory	JJ
cord-350182-s10nong7	50	16	cytokines	cytokine	NNS
cord-350182-s10nong7	50	17	during	during	IN
cord-350182-s10nong7	50	18	the	the	DT
cord-350182-s10nong7	50	19	delayed	delay	VBN
cord-350182-s10nong7	50	20	innate	innate	JJ
cord-350182-s10nong7	50	21	immunity	immunity	NN
cord-350182-s10nong7	50	22	potentiates	potentiate	VBZ
cord-350182-s10nong7	50	23	the	the	DT
cord-350182-s10nong7	50	24	occurrence	occurrence	NN
cord-350182-s10nong7	50	25	of	of	IN
cord-350182-s10nong7	50	26	severe	severe	JJ
cord-350182-s10nong7	50	27	respiratory	respiratory	JJ
cord-350182-s10nong7	50	28	manifestations	manifestation	NNS
cord-350182-s10nong7	50	29	,	,	,
cord-350182-s10nong7	50	30	whilst	whilst	IN
cord-350182-s10nong7	50	31	the	the	DT
cord-350182-s10nong7	50	32	progression	progression	NN
cord-350182-s10nong7	50	33	to	to	IN
cord-350182-s10nong7	50	34	adaptive	adaptive	JJ
cord-350182-s10nong7	50	35	immunity	immunity	NN
cord-350182-s10nong7	50	36	is	be	VBZ
cord-350182-s10nong7	50	37	correlated	correlate	VBN
cord-350182-s10nong7	50	38	with	with	IN
cord-350182-s10nong7	50	39	recovery	recovery	NN
cord-350182-s10nong7	50	40	[	[	-LRB-
cord-350182-s10nong7	50	41	15	15	CD
cord-350182-s10nong7	50	42	]	]	-RRB-
cord-350182-s10nong7	50	43	.	.	.
cord-350182-s10nong7	51	1	Diabetes	diabetes	NN
cord-350182-s10nong7	51	2	mellitus	mellitus	NN
cord-350182-s10nong7	51	3	is	be	VBZ
cord-350182-s10nong7	51	4	a	a	DT
cord-350182-s10nong7	51	5	clinical	clinical	JJ
cord-350182-s10nong7	51	6	syndrome	syndrome	NN
cord-350182-s10nong7	51	7	of	of	IN
cord-350182-s10nong7	51	8	impaired	impaired	JJ
cord-350182-s10nong7	51	9	glucose	glucose	NN
cord-350182-s10nong7	51	10	metabolism	metabolism	NN
cord-350182-s10nong7	51	11	with	with	IN
cord-350182-s10nong7	51	12	inappropriate	inappropriate	JJ
cord-350182-s10nong7	51	13	hyperglycaemia	hyperglycaemia	NN
cord-350182-s10nong7	51	14	due	due	JJ
cord-350182-s10nong7	51	15	to	to	IN
cord-350182-s10nong7	51	16	absolute	absolute	JJ
cord-350182-s10nong7	51	17	or	or	CC
cord-350182-s10nong7	51	18	relative	relative	JJ
cord-350182-s10nong7	51	19	deficiency	deficiency	NN
cord-350182-s10nong7	51	20	in	in	IN
cord-350182-s10nong7	51	21	insulin	insulin	NN
cord-350182-s10nong7	51	22	secretion	secretion	NN
cord-350182-s10nong7	51	23	,	,	,
cord-350182-s10nong7	51	24	resistance	resistance	NN
cord-350182-s10nong7	51	25	to	to	IN
cord-350182-s10nong7	51	26	insulin	insulin	NN
cord-350182-s10nong7	51	27	action	action	NN
cord-350182-s10nong7	51	28	,	,	,
cord-350182-s10nong7	51	29	or	or	CC
cord-350182-s10nong7	51	30	both	both	DT
cord-350182-s10nong7	51	31	[	[	-LRB-
cord-350182-s10nong7	51	32	16	16	CD
cord-350182-s10nong7	51	33	]	]	-RRB-
cord-350182-s10nong7	51	34	.	.	.
cord-350182-s10nong7	52	1	The	the	DT
cord-350182-s10nong7	52	2	most	most	RBS
cord-350182-s10nong7	52	3	common	common	JJ
cord-350182-s10nong7	52	4	types	type	NNS
cord-350182-s10nong7	52	5	of	of	IN
cord-350182-s10nong7	52	6	diabetes	diabetes	NN
cord-350182-s10nong7	52	7	mellitus	mellitus	NN
cord-350182-s10nong7	52	8	include	include	VBP
cord-350182-s10nong7	52	9	type	type	NN
cord-350182-s10nong7	52	10	1	1	CD
cord-350182-s10nong7	52	11	and	and	CC
cord-350182-s10nong7	52	12	type	type	NN
cord-350182-s10nong7	52	13	2	2	CD
cord-350182-s10nong7	52	14	diabetes	diabetes	NN
cord-350182-s10nong7	52	15	[	[	-LRB-
cord-350182-s10nong7	52	16	17	17	CD
cord-350182-s10nong7	52	17	]	]	-RRB-
cord-350182-s10nong7	52	18	.	.	.
cord-350182-s10nong7	53	1	Although	although	IN
cord-350182-s10nong7	53	2	the	the	DT
cord-350182-s10nong7	53	3	clinical	clinical	JJ
cord-350182-s10nong7	53	4	diagnosis	diagnosis	NN
cord-350182-s10nong7	53	5	of	of	IN
cord-350182-s10nong7	53	6	the	the	DT
cord-350182-s10nong7	53	7	type	type	NN
cord-350182-s10nong7	53	8	of	of	IN
cord-350182-s10nong7	53	9	diabetes	diabetes	NN
cord-350182-s10nong7	53	10	is	be	VBZ
cord-350182-s10nong7	53	11	not	not	RB
cord-350182-s10nong7	53	12	always	always	RB
cord-350182-s10nong7	53	13	straightforward	straightforward	JJ
cord-350182-s10nong7	53	14	,	,	,
cord-350182-s10nong7	53	15	type	type	NN
cord-350182-s10nong7	53	16	1	1	CD
cord-350182-s10nong7	53	17	and	and	CC
cord-350182-s10nong7	53	18	type	type	NN
cord-350182-s10nong7	53	19	2	2	CD
cord-350182-s10nong7	53	20	diabetes	diabete	NNS
cord-350182-s10nong7	53	21	are	be	VBP
cord-350182-s10nong7	53	22	heterogeneous	heterogeneous	JJ
cord-350182-s10nong7	53	23	diseases	disease	NNS
cord-350182-s10nong7	53	24	with	with	IN
cord-350182-s10nong7	53	25	considerably	considerably	RB
cord-350182-s10nong7	53	26	different	different	JJ
cord-350182-s10nong7	53	27	pathophysiology	pathophysiology	NN
cord-350182-s10nong7	53	28	.	.	.
cord-350182-s10nong7	54	1	Type	type	NN
cord-350182-s10nong7	54	2	1	1	CD
cord-350182-s10nong7	54	3	diabetes	diabetes	NN
cord-350182-s10nong7	54	4	is	be	VBZ
cord-350182-s10nong7	54	5	a	a	DT
cord-350182-s10nong7	54	6	catabolic	catabolic	JJ
cord-350182-s10nong7	54	7	disorder	disorder	NN
cord-350182-s10nong7	54	8	in	in	IN
cord-350182-s10nong7	54	9	which	which	WDT
cord-350182-s10nong7	54	10	pancreatic	pancreatic	NN
cord-350182-s10nong7	54	11	β	β	NN
cord-350182-s10nong7	54	12	-	-	HYPH
cord-350182-s10nong7	54	13	cells	cell	NNS
cord-350182-s10nong7	54	14	fail	fail	VBP
cord-350182-s10nong7	54	15	to	to	TO
cord-350182-s10nong7	54	16	respond	respond	VB
cord-350182-s10nong7	54	17	to	to	IN
cord-350182-s10nong7	54	18	all	all	DT
cord-350182-s10nong7	54	19	insulinogenic	insulinogenic	JJ
cord-350182-s10nong7	54	20	stimuli	stimulus	NNS
cord-350182-s10nong7	54	21	mainly	mainly	RB
cord-350182-s10nong7	54	22	due	due	JJ
cord-350182-s10nong7	54	23	to	to	IN
cord-350182-s10nong7	54	24	immune	immune	NN
cord-350182-s10nong7	54	25	-	-	HYPH
cord-350182-s10nong7	54	26	mediated	mediate	VBN
cord-350182-s10nong7	54	27	and	and	CC
cord-350182-s10nong7	54	28	less	less	RBR
cord-350182-s10nong7	54	29	frequently	frequently	RB
cord-350182-s10nong7	54	30	due	due	JJ
cord-350182-s10nong7	54	31	to	to	IN
cord-350182-s10nong7	54	32	idiopathic	idiopathic	JJ
cord-350182-s10nong7	54	33	destruction	destruction	NN
cord-350182-s10nong7	54	34	.	.	.
cord-350182-s10nong7	55	1	[	[	-LRB-
cord-350182-s10nong7	55	2	18	18	CD
cord-350182-s10nong7	55	3	,	,	,
cord-350182-s10nong7	55	4	19	19	CD
cord-350182-s10nong7	55	5	]	]	-RRB-
cord-350182-s10nong7	55	6	.	.	.
cord-350182-s10nong7	56	1	Type	type	NN
cord-350182-s10nong7	56	2	2diabetes	2diabetes	CD
cord-350182-s10nong7	56	3	is	be	VBZ
cord-350182-s10nong7	56	4	characterised	characterise	VBN
cord-350182-s10nong7	56	5	by	by	IN
cord-350182-s10nong7	56	6	various	various	JJ
cord-350182-s10nong7	56	7	degrees	degree	NNS
cord-350182-s10nong7	56	8	of	of	IN
cord-350182-s10nong7	56	9	resistance	resistance	NN
cord-350182-s10nong7	56	10	to	to	IN
cord-350182-s10nong7	56	11	insulin	insulin	NN
cord-350182-s10nong7	56	12	action	action	NN
cord-350182-s10nong7	56	13	and	and	CC
cord-350182-s10nong7	56	14	insulin	insulin	NN
cord-350182-s10nong7	56	15	secretory	secretory	JJ
cord-350182-s10nong7	56	16	defect	defect	NN
cord-350182-s10nong7	56	17	and	and	CC
cord-350182-s10nong7	56	18	is	be	VBZ
cord-350182-s10nong7	56	19	associated	associate	VBN
cord-350182-s10nong7	56	20	with	with	IN
cord-350182-s10nong7	56	21	other	other	JJ
cord-350182-s10nong7	56	22	metabolic	metabolic	JJ
cord-350182-s10nong7	56	23	disorders	disorder	NNS
cord-350182-s10nong7	56	24	of	of	IN
cord-350182-s10nong7	56	25	the	the	DT
cord-350182-s10nong7	56	26	muscle	muscle	NN
cord-350182-s10nong7	56	27	tissue	tissue	NN
cord-350182-s10nong7	56	28	,	,	,
cord-350182-s10nong7	56	29	liver	liver	NN
cord-350182-s10nong7	56	30	,	,	,
cord-350182-s10nong7	56	31	fat	fat	JJ
cord-350182-s10nong7	56	32	cells	cell	NNS
cord-350182-s10nong7	56	33	,	,	,
cord-350182-s10nong7	56	34	gastrointestinal	gastrointestinal	JJ
cord-350182-s10nong7	56	35	tract	tract	NN
cord-350182-s10nong7	56	36	,	,	,
cord-350182-s10nong7	56	37	pancreatic	pancreatic	NN
cord-350182-s10nong7	56	38	α	α	NN
cord-350182-s10nong7	56	39	-	-	HYPH
cord-350182-s10nong7	56	40	cells	cell	NNS
cord-350182-s10nong7	56	41	,	,	,
cord-350182-s10nong7	56	42	kidneys	kidney	NNS
cord-350182-s10nong7	56	43	,	,	,
cord-350182-s10nong7	56	44	and	and	CC
cord-350182-s10nong7	56	45	brain	brain	NN
cord-350182-s10nong7	56	46	[	[	-LRB-
cord-350182-s10nong7	56	47	20	20	CD
cord-350182-s10nong7	56	48	]	]	-RRB-
cord-350182-s10nong7	56	49	.	.	.
cord-350182-s10nong7	57	1	The	the	DT
cord-350182-s10nong7	57	2	global	global	JJ
cord-350182-s10nong7	57	3	prevalence	prevalence	NN
cord-350182-s10nong7	57	4	of	of	IN
cord-350182-s10nong7	57	5	diabetes	diabetes	NN
cord-350182-s10nong7	57	6	mellitus	mellitus	NN
cord-350182-s10nong7	57	7	has	have	VBZ
cord-350182-s10nong7	57	8	risen	rise	VBN
cord-350182-s10nong7	57	9	dramatically	dramatically	RB
cord-350182-s10nong7	57	10	over	over	IN
cord-350182-s10nong7	57	11	the	the	DT
cord-350182-s10nong7	57	12	past	past	JJ
cord-350182-s10nong7	57	13	forty	forty	CD
cord-350182-s10nong7	57	14	years	year	NNS
cord-350182-s10nong7	57	15	and	and	CC
cord-350182-s10nong7	57	16	it	-PRON-	PRP
cord-350182-s10nong7	57	17	is	be	VBZ
cord-350182-s10nong7	57	18	expected	expect	VBN
cord-350182-s10nong7	57	19	to	to	TO
cord-350182-s10nong7	57	20	grow	grow	VB
cord-350182-s10nong7	57	21	further	further	RB
cord-350182-s10nong7	57	22	over	over	IN
cord-350182-s10nong7	57	23	the	the	DT
cord-350182-s10nong7	57	24	next	next	JJ
cord-350182-s10nong7	57	25	decades	decade	NNS
cord-350182-s10nong7	57	26	.	.	.
cord-350182-s10nong7	58	1	In	in	IN
cord-350182-s10nong7	58	2	2019	2019	CD
cord-350182-s10nong7	58	3	,	,	,
cord-350182-s10nong7	58	4	it	-PRON-	PRP
cord-350182-s10nong7	58	5	was	be	VBD
cord-350182-s10nong7	58	6	approximately	approximately	RB
cord-350182-s10nong7	58	7	9.3	9.3	CD
cord-350182-s10nong7	58	8	%	%	NN
cord-350182-s10nong7	58	9	(	(	-LRB-
cord-350182-s10nong7	58	10	463	463	CD
cord-350182-s10nong7	58	11	million	million	CD
cord-350182-s10nong7	58	12	people	people	NNS
cord-350182-s10nong7	58	13	)	)	-RRB-
cord-350182-s10nong7	58	14	and	and	CC
cord-350182-s10nong7	58	15	it	-PRON-	PRP
cord-350182-s10nong7	58	16	is	be	VBZ
cord-350182-s10nong7	58	17	estimated	estimate	VBN
cord-350182-s10nong7	58	18	to	to	TO
cord-350182-s10nong7	58	19	rise	rise	VB
cord-350182-s10nong7	58	20	around	around	RB
cord-350182-s10nong7	58	21	to	to	IN
cord-350182-s10nong7	58	22	10.2	10.2	CD
cord-350182-s10nong7	58	23	%	%	NN
cord-350182-s10nong7	58	24	(	(	-LRB-
cord-350182-s10nong7	58	25	578	578	CD
cord-350182-s10nong7	58	26	million	million	CD
cord-350182-s10nong7	58	27	)	)	-RRB-
cord-350182-s10nong7	58	28	by	by	IN
cord-350182-s10nong7	58	29	2030	2030	CD
cord-350182-s10nong7	58	30	and	and	CC
cord-350182-s10nong7	58	31	10.9	10.9	CD
cord-350182-s10nong7	58	32	%	%	NN
cord-350182-s10nong7	58	33	(	(	-LRB-
cord-350182-s10nong7	58	34	700	700	CD
cord-350182-s10nong7	58	35	million	million	CD
cord-350182-s10nong7	58	36	)	)	-RRB-
cord-350182-s10nong7	58	37	by	by	IN
cord-350182-s10nong7	58	38	2045	2045	CD
cord-350182-s10nong7	58	39	[	[	-LRB-
cord-350182-s10nong7	58	40	21	21	CD
cord-350182-s10nong7	58	41	]	]	-RRB-
cord-350182-s10nong7	58	42	.	.	.
cord-350182-s10nong7	59	1	Chronic	Chronic	NNP
cord-350182-s10nong7	59	2	hyperglycaemia	hyperglycaemia	NN
cord-350182-s10nong7	59	3	is	be	VBZ
cord-350182-s10nong7	59	4	associated	associate	VBN
cord-350182-s10nong7	59	5	with	with	IN
cord-350182-s10nong7	59	6	increased	increase	VBN
cord-350182-s10nong7	59	7	susceptibility	susceptibility	NN
cord-350182-s10nong7	59	8	to	to	IN
cord-350182-s10nong7	59	9	pathogens	pathogen	NNS
cord-350182-s10nong7	59	10	.	.	.
cord-350182-s10nong7	60	1	Many	many	JJ
cord-350182-s10nong7	60	2	common	common	JJ
cord-350182-s10nong7	60	3	infections	infection	NNS
cord-350182-s10nong7	60	4	are	be	VBP
cord-350182-s10nong7	60	5	more	more	RBR
cord-350182-s10nong7	60	6	frequent	frequent	JJ
cord-350182-s10nong7	60	7	and	and	CC
cord-350182-s10nong7	60	8	severe	severe	JJ
cord-350182-s10nong7	60	9	in	in	IN
cord-350182-s10nong7	60	10	individuals	individual	NNS
cord-350182-s10nong7	60	11	with	with	IN
cord-350182-s10nong7	60	12	diabetes	diabetes	NN
cord-350182-s10nong7	60	13	mellitus	mellitus	NN
cord-350182-s10nong7	60	14	,	,	,
cord-350182-s10nong7	60	15	whilst	whilst	IN
cord-350182-s10nong7	60	16	some	some	DT
cord-350182-s10nong7	60	17	rare	rare	JJ
cord-350182-s10nong7	60	18	infections	infection	NNS
cord-350182-s10nong7	60	19	(	(	-LRB-
cord-350182-s10nong7	60	20	e.g.	e.g.	RB
cord-350182-s10nong7	60	21	rhinocerebral	rhinocerebral	NNP
cord-350182-s10nong7	60	22	mucormycosis	mucormycosis	NNP
cord-350182-s10nong7	60	23	,	,	,
cord-350182-s10nong7	60	24	emphysematous	emphysematous	JJ
cord-350182-s10nong7	60	25	infections	infection	NNS
cord-350182-s10nong7	60	26	of	of	IN
cord-350182-s10nong7	60	27	the	the	DT
cord-350182-s10nong7	60	28	gallbladder	gallbladder	NN
cord-350182-s10nong7	60	29	and	and	CC
cord-350182-s10nong7	60	30	urinary	urinary	JJ
cord-350182-s10nong7	60	31	tract	tract	NN
cord-350182-s10nong7	60	32	,	,	,
cord-350182-s10nong7	60	33	invasive	invasive	JJ
cord-350182-s10nong7	60	34	otitis	otitis	NN
cord-350182-s10nong7	60	35	externa	externa	NNS
cord-350182-s10nong7	60	36	)	)	-RRB-
cord-350182-s10nong7	60	37	affect	affect	VBP
cord-350182-s10nong7	60	38	almost	almost	RB
cord-350182-s10nong7	60	39	exclusively	exclusively	RB
cord-350182-s10nong7	60	40	the	the	DT
cord-350182-s10nong7	60	41	diabetic	diabetic	JJ
cord-350182-s10nong7	60	42	population	population	NN
cord-350182-s10nong7	60	43	[	[	-LRB-
cord-350182-s10nong7	60	44	22	22	CD
cord-350182-s10nong7	60	45	]	]	-RRB-
cord-350182-s10nong7	60	46	.	.	.
cord-350182-s10nong7	61	1	Although	although	IN
cord-350182-s10nong7	61	2	the	the	DT
cord-350182-s10nong7	61	3	reasons	reason	NNS
cord-350182-s10nong7	61	4	for	for	IN
cord-350182-s10nong7	61	5	this	this	DT
cord-350182-s10nong7	61	6	vulnerability	vulnerability	NN
cord-350182-s10nong7	61	7	are	be	VBP
cord-350182-s10nong7	61	8	not	not	RB
cord-350182-s10nong7	61	9	completely	completely	RB
cord-350182-s10nong7	61	10	defined	define	VBN
cord-350182-s10nong7	61	11	,	,	,
cord-350182-s10nong7	61	12	it	-PRON-	PRP
cord-350182-s10nong7	61	13	is	be	VBZ
cord-350182-s10nong7	61	14	believed	believe	VBN
cord-350182-s10nong7	61	15	that	that	IN
cord-350182-s10nong7	61	16	abnormalities	abnormality	NNS
cord-350182-s10nong7	61	17	in	in	IN
cord-350182-s10nong7	61	18	innate	innate	JJ
cord-350182-s10nong7	61	19	and	and	CC
cord-350182-s10nong7	61	20	adaptive	adaptive	JJ
cord-350182-s10nong7	61	21	immunity	immunity	NN
cord-350182-s10nong7	61	22	,	,	,
cord-350182-s10nong7	61	23	diminished	diminish	VBN
cord-350182-s10nong7	61	24	vascularisation	vascularisation	NN
cord-350182-s10nong7	61	25	,	,	,
cord-350182-s10nong7	61	26	and	and	CC
cord-350182-s10nong7	61	27	facilitation	facilitation	NN
cord-350182-s10nong7	61	28	of	of	IN
cord-350182-s10nong7	61	29	colonisation	colonisation	NN
cord-350182-s10nong7	61	30	and	and	CC
cord-350182-s10nong7	61	31	growth	growth	NN
cord-350182-s10nong7	61	32	of	of	IN
cord-350182-s10nong7	61	33	a	a	DT
cord-350182-s10nong7	61	34	variety	variety	NN
cord-350182-s10nong7	61	35	of	of	IN
cord-350182-s10nong7	61	36	organisms	organism	NNS
cord-350182-s10nong7	61	37	are	be	VBP
cord-350182-s10nong7	61	38	critical	critical	JJ
cord-350182-s10nong7	61	39	factors	factor	NNS
cord-350182-s10nong7	61	40	[	[	-LRB-
cord-350182-s10nong7	61	41	23	23	CD
cord-350182-s10nong7	61	42	]	]	-RRB-
cord-350182-s10nong7	61	43	.	.	.
cord-350182-s10nong7	62	1	In	in	IN
cord-350182-s10nong7	62	2	case	case	NN
cord-350182-s10nong7	62	3	of	of	IN
cord-350182-s10nong7	62	4	viral	viral	JJ
cord-350182-s10nong7	62	5	infections	infection	NNS
cord-350182-s10nong7	62	6	,	,	,
cord-350182-s10nong7	62	7	it	-PRON-	PRP
cord-350182-s10nong7	62	8	is	be	VBZ
cord-350182-s10nong7	62	9	assumed	assume	VBN
cord-350182-s10nong7	62	10	that	that	IN
cord-350182-s10nong7	62	11	impairments	impairment	NNS
cord-350182-s10nong7	62	12	mainly	mainly	RB
cord-350182-s10nong7	62	13	in	in	IN
cord-350182-s10nong7	62	14	innate	innate	JJ
cord-350182-s10nong7	62	15	as	as	RB
cord-350182-s10nong7	62	16	well	well	RB
cord-350182-s10nong7	62	17	as	as	IN
cord-350182-s10nong7	62	18	in	in	IN
cord-350182-s10nong7	62	19	cell	cell	NN
cord-350182-s10nong7	62	20	-	-	HYPH
cord-350182-s10nong7	62	21	mediated	mediate	VBN
cord-350182-s10nong7	62	22	and	and	CC
cord-350182-s10nong7	62	23	humoral	humoral	JJ
cord-350182-s10nong7	62	24	immunity	immunity	NN
cord-350182-s10nong7	62	25	could	could	MD
cord-350182-s10nong7	62	26	contribute	contribute	VB
cord-350182-s10nong7	62	27	to	to	IN
cord-350182-s10nong7	62	28	the	the	DT
cord-350182-s10nong7	62	29	increased	increase	VBN
cord-350182-s10nong7	62	30	susceptibility	susceptibility	NN
cord-350182-s10nong7	62	31	.	.	.
cord-350182-s10nong7	63	1	The	the	DT
cord-350182-s10nong7	63	2	existence	existence	NN
cord-350182-s10nong7	63	3	of	of	IN
cord-350182-s10nong7	63	4	diabetes	diabetes	NN
cord-350182-s10nong7	63	5	is	be	VBZ
cord-350182-s10nong7	63	6	strongly	strongly	RB
cord-350182-s10nong7	63	7	associated	associate	VBN
cord-350182-s10nong7	63	8	with	with	IN
cord-350182-s10nong7	63	9	an	an	DT
cord-350182-s10nong7	63	10	increased	increase	VBN
cord-350182-s10nong7	63	11	risk	risk	NN
cord-350182-s10nong7	63	12	of	of	IN
cord-350182-s10nong7	63	13	developing	develop	VBG
cord-350182-s10nong7	63	14	severe	severe	JJ
cord-350182-s10nong7	63	15	COVID-19	covid-19	NN
cord-350182-s10nong7	63	16	in	in	IN
cord-350182-s10nong7	63	17	case	case	NN
cord-350182-s10nong7	63	18	of	of	IN
cord-350182-s10nong7	63	19	infection	infection	NN
cord-350182-s10nong7	63	20	with	with	IN
cord-350182-s10nong7	63	21	SARS	SARS	NNP
cord-350182-s10nong7	63	22	-	-	HYPH
cord-350182-s10nong7	63	23	CoV-2	CoV-2	NNP
cord-350182-s10nong7	63	24	[	[	-LRB-
cord-350182-s10nong7	63	25	24	24	CD
cord-350182-s10nong7	63	26	,	,	,
cord-350182-s10nong7	63	27	25	25	CD
cord-350182-s10nong7	63	28	]	]	-RRB-
cord-350182-s10nong7	63	29	.	.	.
cord-350182-s10nong7	64	1	However	however	RB
cord-350182-s10nong7	64	2	,	,	,
cord-350182-s10nong7	64	3	it	-PRON-	PRP
cord-350182-s10nong7	64	4	is	be	VBZ
cord-350182-s10nong7	64	5	not	not	RB
cord-350182-s10nong7	64	6	clear	clear	JJ
cord-350182-s10nong7	64	7	how	how	WRB
cord-350182-s10nong7	64	8	diabetes	diabetes	NN
cord-350182-s10nong7	64	9	mellitus	mellitus	NN
cord-350182-s10nong7	64	10	worsens	worsen	VBZ
cord-350182-s10nong7	64	11	the	the	DT
cord-350182-s10nong7	64	12	clinical	clinical	JJ
cord-350182-s10nong7	64	13	presentation	presentation	NN
cord-350182-s10nong7	64	14	of	of	IN
cord-350182-s10nong7	64	15	COVID-19	COVID-19	NNP
cord-350182-s10nong7	64	16	.	.	.
cord-350182-s10nong7	65	1	Several	several	JJ
cord-350182-s10nong7	65	2	suggestions	suggestion	NNS
cord-350182-s10nong7	65	3	can	can	MD
cord-350182-s10nong7	65	4	be	be	VB
cord-350182-s10nong7	65	5	made	make	VBN
cord-350182-s10nong7	65	6	.	.	.
cord-350182-s10nong7	66	1	The	the	DT
cord-350182-s10nong7	66	2	present	present	JJ
cord-350182-s10nong7	66	3	article	article	NN
cord-350182-s10nong7	66	4	supports	support	VBZ
cord-350182-s10nong7	66	5	that	that	WDT
cord-350182-s10nong7	66	6	heightened	heighten	VBD
cord-350182-s10nong7	66	7	inflammatory	inflammatory	JJ
cord-350182-s10nong7	66	8	processes	process	NNS
cord-350182-s10nong7	66	9	constitute	constitute	VBP
cord-350182-s10nong7	66	10	the	the	DT
cord-350182-s10nong7	66	11	main	main	JJ
cord-350182-s10nong7	66	12	pathophysiologic	pathophysiologic	NN
cord-350182-s10nong7	66	13	factor	factor	NN
cord-350182-s10nong7	66	14	for	for	IN
cord-350182-s10nong7	66	15	the	the	DT
cord-350182-s10nong7	66	16	severity	severity	NN
cord-350182-s10nong7	66	17	of	of	IN
cord-350182-s10nong7	66	18	COVID-19	COVID-19	NNP
cord-350182-s10nong7	66	19	among	among	IN
cord-350182-s10nong7	66	20	patients	patient	NNS
cord-350182-s10nong7	66	21	with	with	IN
cord-350182-s10nong7	66	22	diabetes	diabetes	NN
cord-350182-s10nong7	66	23	mellitus	mellitus	NN
cord-350182-s10nong7	66	24	,	,	,
cord-350182-s10nong7	66	25	whilst	whilst	IN
cord-350182-s10nong7	66	26	impairments	impairment	NNS
cord-350182-s10nong7	66	27	in	in	IN
cord-350182-s10nong7	66	28	immune	immune	JJ
cord-350182-s10nong7	66	29	response	response	NN
cord-350182-s10nong7	66	30	and	and	CC
cord-350182-s10nong7	66	31	diabetic	diabetic	JJ
cord-350182-s10nong7	66	32	comorbidities	comorbiditie	NNS
cord-350182-s10nong7	66	33	contribute	contribute	VBP
cord-350182-s10nong7	66	34	to	to	IN
cord-350182-s10nong7	66	35	the	the	DT
cord-350182-s10nong7	66	36	aggravated	aggravated	JJ
cord-350182-s10nong7	66	37	pathogenesis	pathogenesis	NN
cord-350182-s10nong7	66	38	.	.	.
cord-350182-s10nong7	67	1	The	the	DT
cord-350182-s10nong7	67	2	primary	primary	JJ
cord-350182-s10nong7	67	3	hypothesis	hypothesis	NN
cord-350182-s10nong7	67	4	is	be	VBZ
cord-350182-s10nong7	67	5	that	that	DT
cord-350182-s10nong7	67	6	chronic	chronic	JJ
cord-350182-s10nong7	67	7	hyperglycaemia	hyperglycaemia	NN
cord-350182-s10nong7	67	8	is	be	VBZ
cord-350182-s10nong7	67	9	involved	involve	VBN
cord-350182-s10nong7	67	10	in	in	IN
cord-350182-s10nong7	67	11	inflammatory	inflammatory	JJ
cord-350182-s10nong7	67	12	processes	process	NNS
cord-350182-s10nong7	67	13	which	which	WDT
cord-350182-s10nong7	67	14	further	further	RB
cord-350182-s10nong7	67	15	activate	activate	VBP
cord-350182-s10nong7	67	16	monocytes	monocyte	NNS
cord-350182-s10nong7	67	17	and	and	CC
cord-350182-s10nong7	67	18	promote	promote	VB
cord-350182-s10nong7	67	19	the	the	DT
cord-350182-s10nong7	67	20	synthesis	synthesis	NN
cord-350182-s10nong7	67	21	of	of	IN
cord-350182-s10nong7	67	22	pro	pro	JJ
cord-350182-s10nong7	67	23	-	-	JJ
cord-350182-s10nong7	67	24	inflammatory	inflammatory	JJ
cord-350182-s10nong7	67	25	cytokines	cytokine	NNS
cord-350182-s10nong7	67	26	,	,	,
cord-350182-s10nong7	67	27	thus	thus	RB
cord-350182-s10nong7	67	28	aggravating	aggravate	VBG
cord-350182-s10nong7	67	29	inflammation	inflammation	NN
cord-350182-s10nong7	67	30	and	and	CC
cord-350182-s10nong7	67	31	injury	injury	NN
cord-350182-s10nong7	67	32	in	in	IN
cord-350182-s10nong7	67	33	the	the	DT
cord-350182-s10nong7	67	34	lung	lung	NN
cord-350182-s10nong7	67	35	tissue	tissue	NN
cord-350182-s10nong7	67	36	and	and	CC
cord-350182-s10nong7	67	37	worsening	worsen	VBG
cord-350182-s10nong7	67	38	clinical	clinical	JJ
cord-350182-s10nong7	67	39	condition	condition	NN
cord-350182-s10nong7	67	40	.	.	.
cord-350182-s10nong7	68	1	In	in	IN
cord-350182-s10nong7	68	2	this	this	DT
cord-350182-s10nong7	68	3	mechanism	mechanism	NN
cord-350182-s10nong7	68	4	,	,	,
cord-350182-s10nong7	68	5	the	the	DT
cord-350182-s10nong7	68	6	excess	excess	NN
cord-350182-s10nong7	68	7	of	of	IN
cord-350182-s10nong7	68	8	circulating	circulate	VBG
cord-350182-s10nong7	68	9	glucose	glucose	NN
cord-350182-s10nong7	68	10	causes	cause	VBZ
cord-350182-s10nong7	68	11	oxidative	oxidative	JJ
cord-350182-s10nong7	68	12	stress	stress	NN
cord-350182-s10nong7	68	13	in	in	IN
cord-350182-s10nong7	68	14	which	which	WDT
cord-350182-s10nong7	68	15	free	free	JJ
cord-350182-s10nong7	68	16	radical	radical	JJ
cord-350182-s10nong7	68	17	O	o	NN
cord-350182-s10nong7	68	18	2	2	CD
cord-350182-s10nong7	68	19	reduces	reduce	VBZ
cord-350182-s10nong7	68	20	the	the	DT
cord-350182-s10nong7	68	21	availability	availability	NN
cord-350182-s10nong7	68	22	of	of	IN
cord-350182-s10nong7	68	23	nitric	nitric	NN
cord-350182-s10nong7	68	24	oxide	oxide	NN
cord-350182-s10nong7	68	25	(	(	-LRB-
cord-350182-s10nong7	68	26	NO	no	UH
cord-350182-s10nong7	68	27	)	)	-RRB-
cord-350182-s10nong7	68	28	and	and	CC
cord-350182-s10nong7	68	29	activates	activate	VBZ
cord-350182-s10nong7	68	30	a	a	DT
cord-350182-s10nong7	68	31	series	series	NN
cord-350182-s10nong7	68	32	of	of	IN
cord-350182-s10nong7	68	33	pro	pro	JJ
cord-350182-s10nong7	68	34	-	-	JJ
cord-350182-s10nong7	68	35	inflammatory	inflammatory	JJ
cord-350182-s10nong7	68	36	transcription	transcription	NN
cord-350182-s10nong7	68	37	factors	factor	NNS
cord-350182-s10nong7	68	38	leading	lead	VBG
cord-350182-s10nong7	68	39	to	to	IN
cord-350182-s10nong7	68	40	inflammation	inflammation	NN
cord-350182-s10nong7	68	41	.	.	.
cord-350182-s10nong7	69	1	Moreover	moreover	RB
cord-350182-s10nong7	69	2	,	,	,
cord-350182-s10nong7	69	3	hyperglycaemia	hyperglycaemia	NN
cord-350182-s10nong7	69	4	increases	increase	VBZ
cord-350182-s10nong7	69	5	the	the	DT
cord-350182-s10nong7	69	6	expression	expression	NN
cord-350182-s10nong7	69	7	of	of	IN
cord-350182-s10nong7	69	8	tumour	tumour	NN
cord-350182-s10nong7	69	9	necrosis	necrosis	NN
cord-350182-s10nong7	69	10	factor	factor	NN
cord-350182-s10nong7	69	11	-	-	HYPH
cord-350182-s10nong7	69	12	alpha	alpha	NN
cord-350182-s10nong7	69	13	(	(	-LRB-
cord-350182-s10nong7	69	14	TNF	TNF	NNP
cord-350182-s10nong7	69	15	-	-	HYPH
cord-350182-s10nong7	69	16	a	a	LS
cord-350182-s10nong7	69	17	)	)	-RRB-
cord-350182-s10nong7	69	18	and	and	CC
cord-350182-s10nong7	69	19	inteleukin-6	inteleukin-6	NNP
cord-350182-s10nong7	69	20	(	(	-LRB-
cord-350182-s10nong7	69	21	IL-6	IL-6	NNP
cord-350182-s10nong7	69	22	)	)	-RRB-
cord-350182-s10nong7	69	23	which	which	WDT
cord-350182-s10nong7	69	24	further	further	RB
cord-350182-s10nong7	69	25	exacerbate	exacerbate	VBP
cord-350182-s10nong7	69	26	inflammation	inflammation	NN
cord-350182-s10nong7	69	27	[	[	-LRB-
cord-350182-s10nong7	69	28	26	26	CD
cord-350182-s10nong7	69	29	]	]	-RRB-
cord-350182-s10nong7	69	30	.	.	.
cord-350182-s10nong7	70	1	A	a	DT
cord-350182-s10nong7	70	2	higher	high	JJR
cord-350182-s10nong7	70	3	propensity	propensity	NN
cord-350182-s10nong7	70	4	to	to	IN
cord-350182-s10nong7	70	5	infections	infection	NNS
cord-350182-s10nong7	70	6	due	due	JJ
cord-350182-s10nong7	70	7	to	to	IN
cord-350182-s10nong7	70	8	the	the	DT
cord-350182-s10nong7	70	9	involvement	involvement	NN
cord-350182-s10nong7	70	10	of	of	IN
cord-350182-s10nong7	70	11	inflammatory	inflammatory	JJ
cord-350182-s10nong7	70	12	processes	process	NNS
cord-350182-s10nong7	70	13	was	be	VBD
cord-350182-s10nong7	70	14	documented	document	VBN
cord-350182-s10nong7	70	15	in	in	IN
cord-350182-s10nong7	70	16	studies	study	NNS
cord-350182-s10nong7	70	17	involving	involve	VBG
cord-350182-s10nong7	70	18	other	other	JJ
cord-350182-s10nong7	70	19	viruses	virus	NNS
cord-350182-s10nong7	70	20	[	[	-LRB-
cord-350182-s10nong7	70	21	27	27	CD
cord-350182-s10nong7	70	22	]	]	-RRB-
cord-350182-s10nong7	70	23	.	.	.
cord-350182-s10nong7	71	1	In	in	IN
cord-350182-s10nong7	71	2	type	type	NN
cord-350182-s10nong7	71	3	1	1	CD
cord-350182-s10nong7	71	4	diabetes	diabetes	NN
cord-350182-s10nong7	71	5	,	,	,
cord-350182-s10nong7	71	6	autoimmunity	autoimmunity	NN
cord-350182-s10nong7	71	7	induces	induce	VBZ
cord-350182-s10nong7	71	8	an	an	DT
cord-350182-s10nong7	71	9	inflammatory	inflammatory	JJ
cord-350182-s10nong7	71	10	activity	activity	NN
cord-350182-s10nong7	71	11	which	which	WDT
cord-350182-s10nong7	71	12	leads	lead	VBZ
cord-350182-s10nong7	71	13	to	to	IN
cord-350182-s10nong7	71	14	pancreatic	pancreatic	NN
cord-350182-s10nong7	71	15	β	β	NN
cord-350182-s10nong7	71	16	-	-	HYPH
cord-350182-s10nong7	71	17	cell	cell	NN
cord-350182-s10nong7	71	18	damage	damage	NN
cord-350182-s10nong7	71	19	.	.	.
cord-350182-s10nong7	72	1	The	the	DT
cord-350182-s10nong7	72	2	resultant	resultant	JJ
cord-350182-s10nong7	72	3	chronic	chronic	NN
cord-350182-s10nong7	72	4	hyperglycaemia	hyperglycaemia	NN
cord-350182-s10nong7	72	5	causes	cause	VBZ
cord-350182-s10nong7	72	6	oxidative	oxidative	JJ
cord-350182-s10nong7	72	7	stress	stress	NN
cord-350182-s10nong7	72	8	,	,	,
cord-350182-s10nong7	72	9	increases	increase	VBZ
cord-350182-s10nong7	72	10	the	the	DT
cord-350182-s10nong7	72	11	secretion	secretion	NN
cord-350182-s10nong7	72	12	of	of	IN
cord-350182-s10nong7	72	13	TNF	TNF	NNP
cord-350182-s10nong7	72	14	-	-	HYPH
cord-350182-s10nong7	72	15	α	α	NNP
cord-350182-s10nong7	72	16	and	and	CC
cord-350182-s10nong7	72	17	IL-6	IL-6	NNP
cord-350182-s10nong7	72	18	and	and	CC
cord-350182-s10nong7	72	19	impairs	impair	VBZ
cord-350182-s10nong7	72	20	NO	no	RB
cord-350182-s10nong7	72	21	-	-	HYPH
cord-350182-s10nong7	72	22	mediated	mediate	VBN
cord-350182-s10nong7	72	23	vasodilatation	vasodilatation	NN
cord-350182-s10nong7	72	24	[	[	-LRB-
cord-350182-s10nong7	72	25	28	28	CD
cord-350182-s10nong7	72	26	]	]	-RRB-
cord-350182-s10nong7	72	27	.	.	.
cord-350182-s10nong7	73	1	In	in	IN
cord-350182-s10nong7	73	2	type	type	NN
cord-350182-s10nong7	73	3	2	2	CD
cord-350182-s10nong7	73	4	diabetes	diabetes	NN
cord-350182-s10nong7	73	5	,	,	,
cord-350182-s10nong7	73	6	inflammation	inflammation	NN
cord-350182-s10nong7	73	7	is	be	VBZ
cord-350182-s10nong7	73	8	also	also	RB
cord-350182-s10nong7	73	9	caused	cause	VBN
cord-350182-s10nong7	73	10	by	by	IN
cord-350182-s10nong7	73	11	systemic	systemic	JJ
cord-350182-s10nong7	73	12	factors	factor	NNS
cord-350182-s10nong7	73	13	,	,	,
cord-350182-s10nong7	73	14	mainly	mainly	RB
cord-350182-s10nong7	73	15	obesity	obesity	NN
cord-350182-s10nong7	73	16	and	and	CC
cord-350182-s10nong7	73	17	subsequently	subsequently	RB
cord-350182-s10nong7	73	18	insulin	insulin	VBP
cord-350182-s10nong7	73	19	resistance	resistance	NN
cord-350182-s10nong7	73	20	.	.	.
cord-350182-s10nong7	74	1	Adipose	adipose	JJ
cord-350182-s10nong7	74	2	tissue	tissue	NN
cord-350182-s10nong7	74	3	enhances	enhance	VBZ
cord-350182-s10nong7	74	4	the	the	DT
cord-350182-s10nong7	74	5	inflammation	inflammation	NN
cord-350182-s10nong7	74	6	process	process	NN
cord-350182-s10nong7	74	7	through	through	IN
cord-350182-s10nong7	74	8	the	the	DT
cord-350182-s10nong7	74	9	action	action	NN
cord-350182-s10nong7	74	10	of	of	IN
cord-350182-s10nong7	74	11	activated	activate	VBN
cord-350182-s10nong7	74	12	macrophages	macrophage	NNS
cord-350182-s10nong7	74	13	and	and	CC
cord-350182-s10nong7	74	14	the	the	DT
cord-350182-s10nong7	74	15	production	production	NN
cord-350182-s10nong7	74	16	of	of	IN
cord-350182-s10nong7	74	17	proinflammatory	proinflammatory	JJ
cord-350182-s10nong7	74	18	cytokines	cytokine	NNS
cord-350182-s10nong7	74	19	(	(	-LRB-
cord-350182-s10nong7	74	20	including	include	VBG
cord-350182-s10nong7	74	21	TNF	TNF	NNP
cord-350182-s10nong7	74	22	-	-	HYPH
cord-350182-s10nong7	74	23	a	a	NNP
cord-350182-s10nong7	74	24	and	and	CC
cord-350182-s10nong7	74	25	IL-6	IL-6	NNP
cord-350182-s10nong7	74	26	)	)	-RRB-
cord-350182-s10nong7	74	27	[	[	-LRB-
cord-350182-s10nong7	74	28	29	29	CD
cord-350182-s10nong7	74	29	,	,	,
cord-350182-s10nong7	74	30	30	30	CD
cord-350182-s10nong7	74	31	]	]	-RRB-
cord-350182-s10nong7	74	32	.	.	.
cord-350182-s10nong7	75	1	Yet	yet	CC
cord-350182-s10nong7	75	2	it	-PRON-	PRP
cord-350182-s10nong7	75	3	remains	remain	VBZ
cord-350182-s10nong7	75	4	unclear	unclear	JJ
cord-350182-s10nong7	75	5	whether	whether	IN
cord-350182-s10nong7	75	6	the	the	DT
cord-350182-s10nong7	75	7	innate	innate	JJ
cord-350182-s10nong7	75	8	immune	immune	JJ
cord-350182-s10nong7	75	9	response	response	NN
cord-350182-s10nong7	75	10	is	be	VBZ
cord-350182-s10nong7	75	11	vitally	vitally	RB
cord-350182-s10nong7	75	12	impaired	impaired	JJ
cord-350182-s10nong7	75	13	in	in	IN
cord-350182-s10nong7	75	14	both	both	DT
cord-350182-s10nong7	75	15	types	type	NNS
cord-350182-s10nong7	75	16	of	of	IN
cord-350182-s10nong7	75	17	diabetes	diabetes	NN
cord-350182-s10nong7	75	18	mellitus	mellitus	NN
cord-350182-s10nong7	75	19	and	and	CC
cord-350182-s10nong7	75	20	whether	whether	IN
cord-350182-s10nong7	75	21	hyperglycaemia	hyperglycaemia	NNP
cord-350182-s10nong7	75	22	favours	favour	VBZ
cord-350182-s10nong7	75	23	the	the	DT
cord-350182-s10nong7	75	24	initial	initial	JJ
cord-350182-s10nong7	75	25	virulence	virulence	NN
cord-350182-s10nong7	75	26	of	of	IN
cord-350182-s10nong7	75	27	SARS	SARS	NNP
cord-350182-s10nong7	75	28	-	-	HYPH
cord-350182-s10nong7	75	29	CoV-2	CoV-2	NNP
cord-350182-s10nong7	75	30	.	.	.
cord-350182-s10nong7	76	1	Diabetes	diabetes	NN
cord-350182-s10nong7	76	2	is	be	VBZ
cord-350182-s10nong7	76	3	a	a	DT
cord-350182-s10nong7	76	4	chronic	chronic	JJ
cord-350182-s10nong7	76	5	condition	condition	NN
cord-350182-s10nong7	76	6	that	that	WDT
cord-350182-s10nong7	76	7	can	can	MD
cord-350182-s10nong7	76	8	affect	affect	VB
cord-350182-s10nong7	76	9	the	the	DT
cord-350182-s10nong7	76	10	body	body	NN
cord-350182-s10nong7	76	11	's	's	POS
cord-350182-s10nong7	76	12	immune	immune	JJ
cord-350182-s10nong7	76	13	response	response	NN
cord-350182-s10nong7	76	14	to	to	IN
cord-350182-s10nong7	76	15	pathogens	pathogen	NNS
cord-350182-s10nong7	76	16	[	[	-LRB-
cord-350182-s10nong7	76	17	31	31	CD
cord-350182-s10nong7	76	18	]	]	-RRB-
cord-350182-s10nong7	76	19	.	.	.
cord-350182-s10nong7	77	1	Indeed	indeed	RB
cord-350182-s10nong7	77	2	,	,	,
cord-350182-s10nong7	77	3	the	the	DT
cord-350182-s10nong7	77	4	proliferative	proliferative	JJ
cord-350182-s10nong7	77	5	response	response	NN
cord-350182-s10nong7	77	6	of	of	IN
cord-350182-s10nong7	77	7	lymphocytes	lymphocyte	NNS
cord-350182-s10nong7	77	8	is	be	VBZ
cord-350182-s10nong7	77	9	impaired	impair	VBN
cord-350182-s10nong7	77	10	in	in	IN
cord-350182-s10nong7	77	11	patients	patient	NNS
cord-350182-s10nong7	77	12	with	with	IN
cord-350182-s10nong7	77	13	diabetes	diabete	NNS
cord-350182-s10nong7	77	14	,	,	,
cord-350182-s10nong7	77	15	particularly	particularly	RB
cord-350182-s10nong7	77	16	among	among	IN
cord-350182-s10nong7	77	17	those	those	DT
cord-350182-s10nong7	77	18	with	with	IN
cord-350182-s10nong7	77	19	poor	poor	JJ
cord-350182-s10nong7	77	20	glycaemic	glycaemic	JJ
cord-350182-s10nong7	77	21	control	control	NN
cord-350182-s10nong7	77	22	[	[	-LRB-
cord-350182-s10nong7	77	23	32	32	CD
cord-350182-s10nong7	77	24	]	]	-RRB-
cord-350182-s10nong7	77	25	,	,	,
cord-350182-s10nong7	77	26	and	and	CC
cord-350182-s10nong7	77	27	low	low	JJ
cord-350182-s10nong7	77	28	lymphocyte	lymphocyte	NN
cord-350182-s10nong7	77	29	count	count	NN
cord-350182-s10nong7	77	30	is	be	VBZ
cord-350182-s10nong7	77	31	a	a	DT
cord-350182-s10nong7	77	32	predictor	predictor	NN
cord-350182-s10nong7	77	33	of	of	IN
cord-350182-s10nong7	77	34	severe	severe	JJ
cord-350182-s10nong7	77	35	prognosis	prognosis	NN
cord-350182-s10nong7	77	36	in	in	IN
cord-350182-s10nong7	77	37	patients	patient	NNS
cord-350182-s10nong7	77	38	with	with	IN
cord-350182-s10nong7	77	39	COVID-19	COVID-19	NNP
cord-350182-s10nong7	77	40	[	[	-LRB-
cord-350182-s10nong7	77	41	33	33	CD
cord-350182-s10nong7	77	42	]	]	-RRB-
cord-350182-s10nong7	77	43	.	.	.
cord-350182-s10nong7	78	1	With	with	IN
cord-350182-s10nong7	78	2	regard	regard	NN
cord-350182-s10nong7	78	3	to	to	IN
cord-350182-s10nong7	78	4	the	the	DT
cord-350182-s10nong7	78	5	production	production	NN
cord-350182-s10nong7	78	6	of	of	IN
cord-350182-s10nong7	78	7	neutralising	neutralise	VBG
cord-350182-s10nong7	78	8	antibodies	antibody	NNS
cord-350182-s10nong7	78	9	,	,	,
cord-350182-s10nong7	78	10	it	-PRON-	PRP
cord-350182-s10nong7	78	11	is	be	VBZ
cord-350182-s10nong7	78	12	possible	possible	JJ
cord-350182-s10nong7	78	13	that	that	IN
cord-350182-s10nong7	78	14	glycosylation	glycosylation	NN
cord-350182-s10nong7	78	15	may	may	MD
cord-350182-s10nong7	78	16	impair	impair	VB
cord-350182-s10nong7	78	17	humoral	humoral	JJ
cord-350182-s10nong7	78	18	immunity	immunity	NN
cord-350182-s10nong7	78	19	,	,	,
cord-350182-s10nong7	78	20	especially	especially	RB
cord-350182-s10nong7	78	21	in	in	IN
cord-350182-s10nong7	78	22	patients	patient	NNS
cord-350182-s10nong7	78	23	with	with	IN
cord-350182-s10nong7	78	24	high	high	JJ
cord-350182-s10nong7	78	25	HbA	HbA	NNP
cord-350182-s10nong7	78	26	1c	1c	CD
cord-350182-s10nong7	78	27	values	value	NNS
cord-350182-s10nong7	78	28	[	[	-LRB-
cord-350182-s10nong7	78	29	34	34	CD
cord-350182-s10nong7	78	30	]	]	-RRB-
cord-350182-s10nong7	78	31	.	.	.
cord-350182-s10nong7	79	1	Furthermore	furthermore	RB
cord-350182-s10nong7	79	2	,	,	,
cord-350182-s10nong7	79	3	patients	patient	NNS
cord-350182-s10nong7	79	4	with	with	IN
cord-350182-s10nong7	79	5	diabetes	diabetes	NN
cord-350182-s10nong7	79	6	mellitus	mellitus	NN
cord-350182-s10nong7	79	7	may	may	MD
cord-350182-s10nong7	79	8	present	present	VB
cord-350182-s10nong7	79	9	dysfunctional	dysfunctional	JJ
cord-350182-s10nong7	79	10	type	type	NN
cord-350182-s10nong7	79	11	IV	IV	NNP
cord-350182-s10nong7	79	12	(	(	-LRB-
cord-350182-s10nong7	79	13	delayed	delay	VBN
cord-350182-s10nong7	79	14	)	)	-RRB-
cord-350182-s10nong7	79	15	hypersensitivity	hypersensitivity	NN
cord-350182-s10nong7	79	16	reaction	reaction	NN
cord-350182-s10nong7	79	17	and	and	CC
cord-350182-s10nong7	79	18	abnormal	abnormal	JJ
cord-350182-s10nong7	79	19	complement	complement	NN
cord-350182-s10nong7	79	20	activation	activation	NN
cord-350182-s10nong7	79	21	[	[	-LRB-
cord-350182-s10nong7	79	22	35	35	CD
cord-350182-s10nong7	79	23	]	]	-RRB-
cord-350182-s10nong7	79	24	which	which	WDT
cord-350182-s10nong7	79	25	may	may	MD
cord-350182-s10nong7	79	26	hinder	hinder	VB
cord-350182-s10nong7	79	27	the	the	DT
cord-350182-s10nong7	79	28	immune	immune	JJ
cord-350182-s10nong7	79	29	response	response	NN
cord-350182-s10nong7	79	30	.	.	.
cord-350182-s10nong7	80	1	Apart	apart	RB
cord-350182-s10nong7	80	2	from	from	IN
cord-350182-s10nong7	80	3	the	the	DT
cord-350182-s10nong7	80	4	defects	defect	NNS
cord-350182-s10nong7	80	5	in	in	IN
cord-350182-s10nong7	80	6	inflammatory	inflammatory	JJ
cord-350182-s10nong7	80	7	and	and	CC
cord-350182-s10nong7	80	8	immune	immune	JJ
cord-350182-s10nong7	80	9	functions	function	NNS
cord-350182-s10nong7	80	10	due	due	IN
cord-350182-s10nong7	80	11	to	to	IN
cord-350182-s10nong7	80	12	hyperglycaemia	hyperglycaemia	NN
cord-350182-s10nong7	80	13	,	,	,
cord-350182-s10nong7	80	14	complications	complication	NNS
cord-350182-s10nong7	80	15	of	of	IN
cord-350182-s10nong7	80	16	diabetes	diabetes	NN
cord-350182-s10nong7	80	17	mellitus	mellitus	NN
cord-350182-s10nong7	80	18	and	and	CC
cord-350182-s10nong7	80	19	treatment	treatment	NN
cord-350182-s10nong7	80	20	regimens	regimen	NNS
cord-350182-s10nong7	80	21	may	may	MD
cord-350182-s10nong7	80	22	be	be	VB
cord-350182-s10nong7	80	23	involved	involve	VBN
cord-350182-s10nong7	80	24	in	in	IN
cord-350182-s10nong7	80	25	the	the	DT
cord-350182-s10nong7	80	26	vulnerability	vulnerability	NN
cord-350182-s10nong7	80	27	of	of	IN
cord-350182-s10nong7	80	28	these	these	DT
cord-350182-s10nong7	80	29	patients	patient	NNS
cord-350182-s10nong7	80	30	.	.	.
cord-350182-s10nong7	81	1	Endothelial	endothelial	JJ
cord-350182-s10nong7	81	2	dysfunction	dysfunction	NN
cord-350182-s10nong7	81	3	,	,	,
cord-350182-s10nong7	81	4	in	in	IN
cord-350182-s10nong7	81	5	particular	particular	JJ
cord-350182-s10nong7	81	6	,	,	,
cord-350182-s10nong7	81	7	may	may	MD
cord-350182-s10nong7	81	8	enable	enable	VB
cord-350182-s10nong7	81	9	SASR	SASR	NNP
cord-350182-s10nong7	81	10	-	-	HYPH
cord-350182-s10nong7	81	11	CoV-2	CoV-2	NNP
cord-350182-s10nong7	81	12	to	to	TO
cord-350182-s10nong7	81	13	have	have	VB
cord-350182-s10nong7	81	14	an	an	DT
cord-350182-s10nong7	81	15	easier	easy	JJR
cord-350182-s10nong7	81	16	access	access	NN
cord-350182-s10nong7	81	17	to	to	IN
cord-350182-s10nong7	81	18	host	host	NN
cord-350182-s10nong7	81	19	cells	cell	NNS
cord-350182-s10nong7	81	20	[	[	-LRB-
cord-350182-s10nong7	81	21	36	36	CD
cord-350182-s10nong7	81	22	]	]	-RRB-
cord-350182-s10nong7	81	23	.	.	.
cord-350182-s10nong7	82	1	In	in	IN
cord-350182-s10nong7	82	2	addition	addition	NN
cord-350182-s10nong7	82	3	,	,	,
cord-350182-s10nong7	82	4	associated	associate	VBN
cord-350182-s10nong7	82	5	diabetic	diabetic	JJ
cord-350182-s10nong7	82	6	comorbidities	comorbiditie	NNS
cord-350182-s10nong7	82	7	and/	and/	NNP
cord-350182-s10nong7	82	8	or	or	CC
cord-350182-s10nong7	82	9	complications	complication	NNS
cord-350182-s10nong7	82	10	,	,	,
cord-350182-s10nong7	82	11	such	such	JJ
cord-350182-s10nong7	82	12	as	as	IN
cord-350182-s10nong7	82	13	hypertension	hypertension	NN
cord-350182-s10nong7	82	14	,	,	,
cord-350182-s10nong7	82	15	cardiovascular	cardiovascular	JJ
cord-350182-s10nong7	82	16	disease	disease	NN
cord-350182-s10nong7	82	17	,	,	,
cord-350182-s10nong7	82	18	and	and	CC
cord-350182-s10nong7	82	19	chronic	chronic	JJ
cord-350182-s10nong7	82	20	kidney	kidney	NN
cord-350182-s10nong7	82	21	disease	disease	NN
cord-350182-s10nong7	82	22	may	may	MD
cord-350182-s10nong7	82	23	act	act	VB
cord-350182-s10nong7	82	24	synergistically	synergistically	RB
cord-350182-s10nong7	82	25	and	and	CC
cord-350182-s10nong7	82	26	further	further	RB
cord-350182-s10nong7	82	27	worsen	worsen	VB
cord-350182-s10nong7	82	28	the	the	DT
cord-350182-s10nong7	82	29	prognosis	prognosis	NN
cord-350182-s10nong7	82	30	[	[	-LRB-
cord-350182-s10nong7	82	31	37	37	CD
cord-350182-s10nong7	82	32	]	]	-RRB-
cord-350182-s10nong7	82	33	.	.	.
cord-350182-s10nong7	83	1	Especially	especially	RB
cord-350182-s10nong7	83	2	persons	person	NNS
cord-350182-s10nong7	83	3	,	,	,
cord-350182-s10nong7	83	4	who	who	WP
cord-350182-s10nong7	83	5	are	be	VBP
cord-350182-s10nong7	83	6	treated	treat	VBN
cord-350182-s10nong7	83	7	with	with	IN
cord-350182-s10nong7	83	8	ACE	ACE	NNP
cord-350182-s10nong7	83	9	inhibitors	inhibitor	NNS
cord-350182-s10nong7	83	10	or	or	CC
cord-350182-s10nong7	83	11	angiotensin	angiotensin	NN
cord-350182-s10nong7	83	12	2	2	CD
cord-350182-s10nong7	83	13	receptor	receptor	NN
cord-350182-s10nong7	83	14	blockers	blocker	NNS
cord-350182-s10nong7	83	15	,	,	,
cord-350182-s10nong7	83	16	have	have	VBP
cord-350182-s10nong7	83	17	increased	increase	VBN
cord-350182-s10nong7	83	18	expression	expression	NN
cord-350182-s10nong7	83	19	of	of	IN
cord-350182-s10nong7	83	20	ACE2	ACE2	NNP
cord-350182-s10nong7	83	21	which	which	WDT
cord-350182-s10nong7	83	22	could	could	MD
cord-350182-s10nong7	83	23	potentially	potentially	RB
cord-350182-s10nong7	83	24	facilitate	facilitate	VB
cord-350182-s10nong7	83	25	the	the	DT
cord-350182-s10nong7	83	26	infection	infection	NN
cord-350182-s10nong7	83	27	with	with	IN
cord-350182-s10nong7	83	28	SARS	SARS	NNP
cord-350182-s10nong7	83	29	-	-	HYPH
cord-350182-s10nong7	83	30	CoV-2	CoV-2	NNP
cord-350182-s10nong7	83	31	[	[	-LRB-
cord-350182-s10nong7	83	32	38	38	CD
cord-350182-s10nong7	83	33	]	]	-RRB-
cord-350182-s10nong7	83	34	.	.	.
cord-350182-s10nong7	84	1	COVID-19	COVID-19	NNP
cord-350182-s10nong7	84	2	has	have	VBZ
cord-350182-s10nong7	84	3	evolved	evolve	VBN
cord-350182-s10nong7	84	4	to	to	IN
cord-350182-s10nong7	84	5	a	a	DT
cord-350182-s10nong7	84	6	public	public	JJ
cord-350182-s10nong7	84	7	health	health	NN
cord-350182-s10nong7	84	8	crisis	crisis	NN
cord-350182-s10nong7	84	9	.	.	.
cord-350182-s10nong7	85	1	Currently	currently	RB
cord-350182-s10nong7	85	2	,	,	,
cord-350182-s10nong7	85	3	there	there	EX
cord-350182-s10nong7	85	4	is	be	VBZ
cord-350182-s10nong7	85	5	a	a	DT
cord-350182-s10nong7	85	6	lack	lack	NN
cord-350182-s10nong7	85	7	of	of	IN
cord-350182-s10nong7	85	8	specific	specific	JJ
cord-350182-s10nong7	85	9	treatments	treatment	NNS
cord-350182-s10nong7	85	10	,	,	,
cord-350182-s10nong7	85	11	and	and	CC
cord-350182-s10nong7	85	12	only	only	RB
cord-350182-s10nong7	85	13	general	general	JJ
cord-350182-s10nong7	85	14	preventive	preventive	JJ
cord-350182-s10nong7	85	15	strategies	strategy	NNS
cord-350182-s10nong7	85	16	are	be	VBP
cord-350182-s10nong7	85	17	available	available	JJ
cord-350182-s10nong7	85	18	.	.	.
cord-350182-s10nong7	86	1	Within	within	IN
cord-350182-s10nong7	86	2	this	this	DT
cord-350182-s10nong7	86	3	context	context	NN
cord-350182-s10nong7	86	4	,	,	,
cord-350182-s10nong7	86	5	appropriate	appropriate	JJ
cord-350182-s10nong7	86	6	guidance	guidance	NN
cord-350182-s10nong7	86	7	of	of	IN
cord-350182-s10nong7	86	8	patients	patient	NNS
cord-350182-s10nong7	86	9	with	with	IN
cord-350182-s10nong7	86	10	diabetes	diabetes	NN
cord-350182-s10nong7	86	11	should	should	MD
cord-350182-s10nong7	86	12	be	be	VB
cord-350182-s10nong7	86	13	a	a	DT
cord-350182-s10nong7	86	14	priority	priority	NN
cord-350182-s10nong7	86	15	.	.	.
cord-350182-s10nong7	87	1	Social	social	JJ
cord-350182-s10nong7	87	2	distancing	distancing	NN
cord-350182-s10nong7	87	3	and	and	CC
cord-350182-s10nong7	87	4	practicing	practice	VBG
cord-350182-s10nong7	87	5	good	good	JJ
cord-350182-s10nong7	87	6	hygiene	hygiene	NN
cord-350182-s10nong7	87	7	are	be	VBP
cord-350182-s10nong7	87	8	invaluable	invaluable	JJ
cord-350182-s10nong7	87	9	tools	tool	NNS
cord-350182-s10nong7	87	10	for	for	IN
cord-350182-s10nong7	87	11	diminishing	diminish	VBG
cord-350182-s10nong7	87	12	the	the	DT
cord-350182-s10nong7	87	13	transmission	transmission	NN
cord-350182-s10nong7	87	14	of	of	IN
cord-350182-s10nong7	87	15	SARS	SARS	NNP
cord-350182-s10nong7	87	16	-	-	HYPH
cord-350182-s10nong7	87	17	CoV-2	CoV-2	NNP
cord-350182-s10nong7	87	18	.	.	.
cord-350182-s10nong7	88	1	In	in	IN
cord-350182-s10nong7	88	2	case	case	NN
cord-350182-s10nong7	88	3	of	of	IN
cord-350182-s10nong7	88	4	extended	extended	JJ
cord-350182-s10nong7	88	5	periods	period	NNS
cord-350182-s10nong7	88	6	of	of	IN
cord-350182-s10nong7	88	7	isolation	isolation	NN
cord-350182-s10nong7	88	8	,	,	,
cord-350182-s10nong7	88	9	individuals	individual	NNS
cord-350182-s10nong7	88	10	with	with	IN
cord-350182-s10nong7	88	11	diabetes	diabetes	NN
cord-350182-s10nong7	88	12	should	should	MD
cord-350182-s10nong7	88	13	secure	secure	VB
cord-350182-s10nong7	88	14	access	access	NN
cord-350182-s10nong7	88	15	to	to	IN
cord-350182-s10nong7	88	16	medications	medication	NNS
cord-350182-s10nong7	88	17	and	and	CC
cord-350182-s10nong7	88	18	consumable	consumable	JJ
cord-350182-s10nong7	88	19	supplies	supply	NNS
cord-350182-s10nong7	88	20	,	,	,
cord-350182-s10nong7	88	21	such	such	JJ
cord-350182-s10nong7	88	22	as	as	IN
cord-350182-s10nong7	88	23	insulin	insulin	NN
cord-350182-s10nong7	88	24	,	,	,
cord-350182-s10nong7	88	25	glucose	glucose	NN
cord-350182-s10nong7	88	26	test	test	NN
cord-350182-s10nong7	88	27	strips	strip	NNS
cord-350182-s10nong7	88	28	,	,	,
cord-350182-s10nong7	88	29	disinfectants	disinfectant	NNS
cord-350182-s10nong7	88	30	,	,	,
cord-350182-s10nong7	88	31	and	and	CC
cord-350182-s10nong7	88	32	ensure	ensure	VB
cord-350182-s10nong7	88	33	unimpeded	unimpeded	JJ
cord-350182-s10nong7	88	34	communication	communication	NN
cord-350182-s10nong7	88	35	with	with	IN
cord-350182-s10nong7	88	36	health	health	NN
cord-350182-s10nong7	88	37	care	care	NN
cord-350182-s10nong7	88	38	professionals	professional	NNS
cord-350182-s10nong7	88	39	,	,	,
cord-350182-s10nong7	88	40	including	include	VBG
cord-350182-s10nong7	88	41	the	the	DT
cord-350182-s10nong7	88	42	use	use	NN
cord-350182-s10nong7	88	43	of	of	IN
cord-350182-s10nong7	88	44	phone	phone	NN
cord-350182-s10nong7	88	45	and	and	CC
cord-350182-s10nong7	88	46	video	video	NN
cord-350182-s10nong7	88	47	calls	call	NNS
cord-350182-s10nong7	88	48	to	to	TO
cord-350182-s10nong7	88	49	minimise	minimise	VB
cord-350182-s10nong7	88	50	face	face	NN
cord-350182-s10nong7	88	51	-	-	HYPH
cord-350182-s10nong7	88	52	to	to	IN
cord-350182-s10nong7	88	53	-	-	HYPH
cord-350182-s10nong7	88	54	face	face	NN
cord-350182-s10nong7	88	55	contact	contact	NN
cord-350182-s10nong7	88	56	[	[	-LRB-
cord-350182-s10nong7	88	57	39	39	CD
cord-350182-s10nong7	88	58	]	]	-RRB-
cord-350182-s10nong7	88	59	.	.	.
cord-350182-s10nong7	89	1	Although	although	IN
cord-350182-s10nong7	89	2	individuals	individual	NNS
cord-350182-s10nong7	89	3	with	with	IN
cord-350182-s10nong7	89	4	diabetes	diabete	NNS
cord-350182-s10nong7	89	5	do	do	VBP
cord-350182-s10nong7	89	6	not	not	RB
cord-350182-s10nong7	89	7	appear	appear	VB
cord-350182-s10nong7	89	8	to	to	TO
cord-350182-s10nong7	89	9	contract	contract	VB
cord-350182-s10nong7	89	10	SARS	SARS	NNP
cord-350182-s10nong7	89	11	-	-	HYPH
cord-350182-s10nong7	89	12	CoV-2	CoV-2	NNP
cord-350182-s10nong7	89	13	at	at	IN
cord-350182-s10nong7	89	14	an	an	DT
cord-350182-s10nong7	89	15	increased	increase	VBN
cord-350182-s10nong7	89	16	rate	rate	NN
cord-350182-s10nong7	89	17	compared	compare	VBN
cord-350182-s10nong7	89	18	to	to	IN
cord-350182-s10nong7	89	19	the	the	DT
cord-350182-s10nong7	89	20	general	general	JJ
cord-350182-s10nong7	89	21	population	population	NN
cord-350182-s10nong7	89	22	[	[	-LRB-
cord-350182-s10nong7	89	23	40	40	CD
cord-350182-s10nong7	89	24	]	]	-RRB-
cord-350182-s10nong7	89	25	,	,	,
cord-350182-s10nong7	89	26	poor	poor	JJ
cord-350182-s10nong7	89	27	control	control	NN
cord-350182-s10nong7	89	28	of	of	IN
cord-350182-s10nong7	89	29	diabetes	diabetes	NN
cord-350182-s10nong7	89	30	is	be	VBZ
cord-350182-s10nong7	89	31	associated	associate	VBN
cord-350182-s10nong7	89	32	with	with	IN
cord-350182-s10nong7	89	33	a	a	DT
cord-350182-s10nong7	89	34	higher	high	JJR
cord-350182-s10nong7	89	35	risk	risk	NN
cord-350182-s10nong7	89	36	for	for	IN
cord-350182-s10nong7	89	37	adverse	adverse	JJ
cord-350182-s10nong7	89	38	clinical	clinical	JJ
cord-350182-s10nong7	89	39	outcomes	outcome	NNS
cord-350182-s10nong7	89	40	.	.	.
cord-350182-s10nong7	90	1	Therefore	therefore	RB
cord-350182-s10nong7	90	2	,	,	,
cord-350182-s10nong7	90	3	it	-PRON-	PRP
cord-350182-s10nong7	90	4	is	be	VBZ
cord-350182-s10nong7	90	5	important	important	JJ
cord-350182-s10nong7	90	6	that	that	IN
cord-350182-s10nong7	90	7	persons	person	NNS
cord-350182-s10nong7	90	8	with	with	IN
cord-350182-s10nong7	90	9	diabetes	diabetes	NN
cord-350182-s10nong7	90	10	mellitus	mellitus	NN
cord-350182-s10nong7	90	11	maintain	maintain	VBP
cord-350182-s10nong7	90	12	an	an	DT
cord-350182-s10nong7	90	13	optimal	optimal	JJ
cord-350182-s10nong7	90	14	glycaemic	glycaemic	JJ
cord-350182-s10nong7	90	15	control	control	NN
cord-350182-s10nong7	90	16	during	during	IN
cord-350182-s10nong7	90	17	a	a	DT
cord-350182-s10nong7	90	18	SARS	SARS	NNP
cord-350182-s10nong7	90	19	-	-	HYPH
cord-350182-s10nong7	90	20	CoV-2	CoV-2	NNP
cord-350182-s10nong7	90	21	outbreak	outbreak	NN
cord-350182-s10nong7	90	22	.	.	.
cord-350182-s10nong7	91	1	Regular	regular	JJ
cord-350182-s10nong7	91	2	monitoring	monitoring	NN
cord-350182-s10nong7	91	3	of	of	IN
cord-350182-s10nong7	91	4	blood	blood	NN
cord-350182-s10nong7	91	5	glucose	glucose	NN
cord-350182-s10nong7	91	6	levels	level	NNS
cord-350182-s10nong7	91	7	(	(	-LRB-
cord-350182-s10nong7	91	8	and	and	CC
cord-350182-s10nong7	91	9	urinary	urinary	JJ
cord-350182-s10nong7	91	10	ketones	ketone	NNS
cord-350182-s10nong7	91	11	when	when	WRB
cord-350182-s10nong7	91	12	needed	need	VBN
cord-350182-s10nong7	91	13	)	)	-RRB-
cord-350182-s10nong7	91	14	and	and	CC
cord-350182-s10nong7	91	15	adherence	adherence	NN
cord-350182-s10nong7	91	16	to	to	IN
cord-350182-s10nong7	91	17	treatment	treatment	NN
cord-350182-s10nong7	91	18	are	be	VBP
cord-350182-s10nong7	91	19	necessary	necessary	JJ
cord-350182-s10nong7	91	20	for	for	IN
cord-350182-s10nong7	91	21	this	this	DT
cord-350182-s10nong7	91	22	purpose	purpose	NN
cord-350182-s10nong7	91	23	.	.	.
cord-350182-s10nong7	92	1	Attention	attention	NN
cord-350182-s10nong7	92	2	to	to	IN
cord-350182-s10nong7	92	3	proper	proper	JJ
cord-350182-s10nong7	92	4	nutrition	nutrition	NN
cord-350182-s10nong7	92	5	and	and	CC
cord-350182-s10nong7	92	6	physical	physical	JJ
cord-350182-s10nong7	92	7	activity	activity	NN
cord-350182-s10nong7	92	8	(	(	-LRB-
cord-350182-s10nong7	92	9	such	such	JJ
cord-350182-s10nong7	92	10	as	as	IN
cord-350182-s10nong7	92	11	indoor	indoor	JJ
cord-350182-s10nong7	92	12	exercise	exercise	NN
cord-350182-s10nong7	92	13	and	and	CC
cord-350182-s10nong7	92	14	unescorted	unescorted	JJ
cord-350182-s10nong7	92	15	walking	walking	NN
cord-350182-s10nong7	92	16	)	)	-RRB-
cord-350182-s10nong7	92	17	are	be	VBP
cord-350182-s10nong7	92	18	also	also	RB
cord-350182-s10nong7	92	19	important	important	JJ
cord-350182-s10nong7	92	20	[	[	-LRB-
cord-350182-s10nong7	92	21	41	41	CD
cord-350182-s10nong7	92	22	]	]	-RRB-
cord-350182-s10nong7	92	23	.	.	.
cord-350182-s10nong7	93	1	The	the	DT
cord-350182-s10nong7	93	2	health	health	NN
cord-350182-s10nong7	93	3	crisis	crisis	NN
cord-350182-s10nong7	93	4	due	due	IN
cord-350182-s10nong7	93	5	to	to	IN
cord-350182-s10nong7	93	6	the	the	DT
cord-350182-s10nong7	93	7	COVID-19	COVID-19	NNP
cord-350182-s10nong7	93	8	pandemic	pandemic	NN
cord-350182-s10nong7	93	9	has	have	VBZ
cord-350182-s10nong7	93	10	been	be	VBN
cord-350182-s10nong7	93	11	a	a	DT
cord-350182-s10nong7	93	12	global	global	JJ
cord-350182-s10nong7	93	13	challenge	challenge	NN
cord-350182-s10nong7	93	14	for	for	IN
cord-350182-s10nong7	93	15	states	state	NNS
cord-350182-s10nong7	93	16	,	,	,
cord-350182-s10nong7	93	17	care	care	VB
cord-350182-s10nong7	93	18	systems	system	NNS
cord-350182-s10nong7	93	19	and	and	CC
cord-350182-s10nong7	93	20	individuals	individual	NNS
cord-350182-s10nong7	93	21	.	.	.
cord-350182-s10nong7	94	1	SARS	SARS	NNP
cord-350182-s10nong7	94	2	-	-	HYPH
cord-350182-s10nong7	94	3	CoV-2	CoV-2	NNP
cord-350182-s10nong7	94	4	has	have	VBZ
cord-350182-s10nong7	94	5	been	be	VBN
cord-350182-s10nong7	94	6	exceptionally	exceptionally	RB
cord-350182-s10nong7	94	7	infectious	infectious	JJ
cord-350182-s10nong7	94	8	and	and	CC
cord-350182-s10nong7	94	9	pathogenic	pathogenic	JJ
cord-350182-s10nong7	94	10	for	for	IN
cord-350182-s10nong7	94	11	humans	human	NNS
cord-350182-s10nong7	94	12	.	.	.
cord-350182-s10nong7	95	1	Patients	patient	NNS
cord-350182-s10nong7	95	2	with	with	IN
cord-350182-s10nong7	95	3	diabetes	diabetes	NN
cord-350182-s10nong7	95	4	mellitus	mellitus	NN
cord-350182-s10nong7	95	5	need	need	VBP
cord-350182-s10nong7	95	6	to	to	TO
cord-350182-s10nong7	95	7	be	be	VB
cord-350182-s10nong7	95	8	in	in	IN
cord-350182-s10nong7	95	9	the	the	DT
cord-350182-s10nong7	95	10	core	core	NN
cord-350182-s10nong7	95	11	of	of	IN
cord-350182-s10nong7	95	12	health	health	NN
cord-350182-s10nong7	95	13	care	care	NN
cord-350182-s10nong7	95	14	attention	attention	NN
cord-350182-s10nong7	95	15	because	because	IN
cord-350182-s10nong7	95	16	of	of	IN
cord-350182-s10nong7	95	17	greater	great	JJR
cord-350182-s10nong7	95	18	risk	risk	NN
cord-350182-s10nong7	95	19	for	for	IN
cord-350182-s10nong7	95	20	severe	severe	JJ
cord-350182-s10nong7	95	21	clinical	clinical	JJ
cord-350182-s10nong7	95	22	course	course	NN
cord-350182-s10nong7	95	23	and	and	CC
cord-350182-s10nong7	95	24	mortality	mortality	NN
cord-350182-s10nong7	95	25	.	.	.
cord-350182-s10nong7	96	1	In	in	IN
cord-350182-s10nong7	96	2	addition	addition	NN
cord-350182-s10nong7	96	3	,	,	,
cord-350182-s10nong7	96	4	the	the	DT
cord-350182-s10nong7	96	5	global	global	JJ
cord-350182-s10nong7	96	6	community	community	NN
cord-350182-s10nong7	96	7	should	should	MD
cord-350182-s10nong7	96	8	focus	focus	VB
cord-350182-s10nong7	96	9	on	on	IN
cord-350182-s10nong7	96	10	the	the	DT
cord-350182-s10nong7	96	11	discovery	discovery	NN
cord-350182-s10nong7	96	12	and	and	CC
cord-350182-s10nong7	96	13	production	production	NN
cord-350182-s10nong7	96	14	of	of	IN
cord-350182-s10nong7	96	15	the	the	DT
cord-350182-s10nong7	96	16	medical	medical	JJ
cord-350182-s10nong7	96	17	means	mean	NNS
cord-350182-s10nong7	96	18	that	that	WDT
cord-350182-s10nong7	96	19	will	will	MD
cord-350182-s10nong7	96	20	affectively	affectively	RB
cord-350182-s10nong7	96	21	protect	protect	VB
cord-350182-s10nong7	96	22	populations	population	NNS
cord-350182-s10nong7	96	23	.	.	.
cord-350182-s10nong7	97	1	Identification	identification	NN
cord-350182-s10nong7	97	2	of	of	IN
cord-350182-s10nong7	97	3	a	a	DT
cord-350182-s10nong7	97	4	novel	novel	JJ
cord-350182-s10nong7	97	5	coronavirus	coronavirus	NN
cord-350182-s10nong7	97	6	causing	cause	VBG
cord-350182-s10nong7	97	7	severe	severe	JJ
cord-350182-s10nong7	97	8	pneumonia	pneumonia	NN
cord-350182-s10nong7	97	9	in	in	IN
cord-350182-s10nong7	97	10	human	human	NN
cord-350182-s10nong7	97	11	:	:	:
cord-350182-s10nong7	98	1	A	a	DT
cord-350182-s10nong7	98	2	descriptive	descriptive	JJ
cord-350182-s10nong7	98	3	study	study	NN
cord-350182-s10nong7	99	1	Structural	structural	JJ
cord-350182-s10nong7	99	2	basis	basis	NN
cord-350182-s10nong7	99	3	for	for	IN
cord-350182-s10nong7	99	4	the	the	DT
cord-350182-s10nong7	99	5	recognition	recognition	NN
cord-350182-s10nong7	99	6	of	of	IN
cord-350182-s10nong7	99	7	SARS	SARS	NNP
cord-350182-s10nong7	99	8	-	-	HYPH
cord-350182-s10nong7	99	9	CoV-2	CoV-2	NNP
cord-350182-s10nong7	99	10	by	by	IN
cord-350182-s10nong7	99	11	full	full	JJ
cord-350182-s10nong7	99	12	-	-	HYPH
cord-350182-s10nong7	99	13	length	length	NN
cord-350182-s10nong7	99	14	human	human	JJ
cord-350182-s10nong7	99	15	ACE2	ACE2	NNP
cord-350182-s10nong7	99	16	Zoonotic	Zoonotic	NNP
cord-350182-s10nong7	99	17	origins	origin	NNS
cord-350182-s10nong7	99	18	of	of	IN
cord-350182-s10nong7	99	19	human	human	JJ
cord-350182-s10nong7	99	20	coronaviruses	coronaviruse	NNS
cord-350182-s10nong7	100	1	The	the	DT
cord-350182-s10nong7	100	2	epidemiology	epidemiology	NN
cord-350182-s10nong7	100	3	and	and	CC
cord-350182-s10nong7	100	4	pathogenesis	pathogenesis	NN
cord-350182-s10nong7	100	5	of	of	IN
cord-350182-s10nong7	100	6	coronavirus	coronavirus	NN
cord-350182-s10nong7	100	7	disease	disease	NN
cord-350182-s10nong7	100	8	(	(	-LRB-
cord-350182-s10nong7	100	9	COVID-19	COVID-19	NNP
cord-350182-s10nong7	100	10	)	)	-RRB-
cord-350182-s10nong7	100	11	outbreak	outbreak	NN
cord-350182-s10nong7	101	1	The	the	DT
cord-350182-s10nong7	101	2	incubation	incubation	NN
cord-350182-s10nong7	101	3	period	period	NN
cord-350182-s10nong7	101	4	of	of	IN
cord-350182-s10nong7	101	5	coronavirus	coronavirus	NN
cord-350182-s10nong7	101	6	disease	disease	NN
cord-350182-s10nong7	101	7	2019	2019	CD
cord-350182-s10nong7	101	8	(	(	-LRB-
cord-350182-s10nong7	101	9	COVID-19	COVID-19	NNP
cord-350182-s10nong7	101	10	)	)	-RRB-
cord-350182-s10nong7	101	11	from	from	IN
cord-350182-s10nong7	101	12	publicly	publicly	RB
cord-350182-s10nong7	101	13	reported	report	VBN
cord-350182-s10nong7	101	14	confirmed	confirm	VBN
cord-350182-s10nong7	101	15	cases	case	NNS
cord-350182-s10nong7	101	16	:	:	:
cord-350182-s10nong7	101	17	Estimation	estimation	NN
cord-350182-s10nong7	101	18	and	and	CC
cord-350182-s10nong7	101	19	application	application	NN
cord-350182-s10nong7	101	20	High	high	JJ
cord-350182-s10nong7	101	21	contagiousness	contagiousness	NN
cord-350182-s10nong7	101	22	and	and	CC
cord-350182-s10nong7	101	23	rapid	rapid	JJ
cord-350182-s10nong7	101	24	spread	spread	NN
cord-350182-s10nong7	101	25	of	of	IN
cord-350182-s10nong7	101	26	severe	severe	JJ
cord-350182-s10nong7	101	27	acute	acute	JJ
cord-350182-s10nong7	101	28	respiratory	respiratory	JJ
cord-350182-s10nong7	101	29	syndrome	syndrome	NN
cord-350182-s10nong7	101	30	coronavirus	coronavirus	NN
cord-350182-s10nong7	101	31	2	2	CD
cord-350182-s10nong7	102	1	Di	Di	NNP
cord-350182-s10nong7	102	2	Napoli	Napoli	NNP
cord-350182-s10nong7	102	3	R.	R.	NNP
cord-350182-s10nong7	102	4	Features	Features	NNP
cord-350182-s10nong7	102	5	,	,	,
cord-350182-s10nong7	102	6	evaluation	evaluation	NN
cord-350182-s10nong7	102	7	and	and	CC
cord-350182-s10nong7	102	8	treatment	treatment	NN
cord-350182-s10nong7	102	9	Coronavirus	Coronavirus	NNP
cord-350182-s10nong7	102	10	Prevalence	prevalence	NN
cord-350182-s10nong7	102	11	of	of	IN
cord-350182-s10nong7	102	12	underlying	underlie	VBG
cord-350182-s10nong7	102	13	diseases	disease	NNS
cord-350182-s10nong7	102	14	in	in	IN
cord-350182-s10nong7	102	15	hospitalized	hospitalize	VBN
cord-350182-s10nong7	102	16	patients	patient	NNS
cord-350182-s10nong7	102	17	with	with	IN
cord-350182-s10nong7	102	18	COVID-19	covid-19	CD
cord-350182-s10nong7	102	19	:	:	:
cord-350182-s10nong7	102	20	A	a	DT
cord-350182-s10nong7	102	21	systematic	systematic	JJ
cord-350182-s10nong7	102	22	review	review	NN
cord-350182-s10nong7	102	23	and	and	CC
cord-350182-s10nong7	102	24	meta	meta	NNP
cord-350182-s10nong7	102	25	-	-	HYPH
cord-350182-s10nong7	102	26	analysis	analysis	NNP
cord-350182-s10nong7	102	27	Structure	Structure	NNP
cord-350182-s10nong7	102	28	,	,	,
cord-350182-s10nong7	102	29	function	function	NN
cord-350182-s10nong7	102	30	,	,	,
cord-350182-s10nong7	102	31	and	and	CC
cord-350182-s10nong7	102	32	antigenicity	antigenicity	NN
cord-350182-s10nong7	102	33	of	of	IN
cord-350182-s10nong7	102	34	the	the	DT
cord-350182-s10nong7	102	35	SARS	SARS	NNP
cord-350182-s10nong7	102	36	-	-	HYPH
cord-350182-s10nong7	102	37	CoV-2	CoV-2	NNP
cord-350182-s10nong7	102	38	spike	spike	NN
cord-350182-s10nong7	102	39	glycoprotein	glycoprotein	NN
cord-350182-s10nong7	102	40	China	China	NNP
cord-350182-s10nong7	102	41	Novel	Novel	NNP
cord-350182-s10nong7	102	42	Coronavirus	Coronavirus	NNP
cord-350182-s10nong7	102	43	Investigating	Investigating	NNP
cord-350182-s10nong7	102	44	and	and	CC
cord-350182-s10nong7	102	45	Research	Research	NNP
cord-350182-s10nong7	102	46	Team	Team	NNP
cord-350182-s10nong7	102	47	.	.	.
cord-350182-s10nong7	103	1	A	a	DT
cord-350182-s10nong7	103	2	novel	novel	JJ
cord-350182-s10nong7	103	3	coronavirus	coronavirus	NN
cord-350182-s10nong7	103	4	from	from	IN
cord-350182-s10nong7	103	5	patients	patient	NNS
cord-350182-s10nong7	103	6	with	with	IN
cord-350182-s10nong7	103	7	pneumonia	pneumonia	NN
cord-350182-s10nong7	103	8	in	in	IN
cord-350182-s10nong7	103	9	China	China	NNP
cord-350182-s10nong7	104	1	Interferon	interferon	NN
cord-350182-s10nong7	104	2	and	and	CC
cord-350182-s10nong7	104	3	cytokine	cytokine	JJ
cord-350182-s10nong7	104	4	responses	response	NNS
cord-350182-s10nong7	104	5	to	to	IN
cord-350182-s10nong7	104	6	SARScoronavirus	SARScoronavirus	NNP
cord-350182-s10nong7	104	7	infection	infection	NN
cord-350182-s10nong7	104	8	Immune	Immune	NNP
cord-350182-s10nong7	104	9	responses	response	NNS
cord-350182-s10nong7	104	10	in	in	IN
cord-350182-s10nong7	104	11	COVID-19	covid-19	JJ
cord-350182-s10nong7	104	12	and	and	CC
cord-350182-s10nong7	104	13	potential	potential	JJ
cord-350182-s10nong7	104	14	vaccines	vaccine	NNS
cord-350182-s10nong7	104	15	:	:	:
cord-350182-s10nong7	104	16	Lessons	lesson	NNS
cord-350182-s10nong7	104	17	learned	learn	VBN
cord-350182-s10nong7	104	18	from	from	IN
cord-350182-s10nong7	104	19	SARS	SARS	NNP
cord-350182-s10nong7	104	20	and	and	CC
cord-350182-s10nong7	104	21	MERS	MERS	NNP
cord-350182-s10nong7	104	22	epidemic	epidemic	NN
cord-350182-s10nong7	104	23	Coronavirus	Coronavirus	NNP
cord-350182-s10nong7	104	24	infections	infection	NNS
cord-350182-s10nong7	104	25	and	and	CC
cord-350182-s10nong7	104	26	immune	immune	JJ
cord-350182-s10nong7	104	27	responses	response	NNS
cord-350182-s10nong7	105	1	SARS	SARS	NNP
cord-350182-s10nong7	105	2	-	-	HYPH
cord-350182-s10nong7	105	3	CoV-2	CoV-2	NNP
cord-350182-s10nong7	105	4	and	and	CC
cord-350182-s10nong7	105	5	COVID-19	covid-19	VB
cord-350182-s10nong7	105	6	in	in	IN
cord-350182-s10nong7	105	7	older	old	JJR
cord-350182-s10nong7	105	8	adults	adult	NNS
cord-350182-s10nong7	105	9	:	:	:
cord-350182-s10nong7	105	10	What	what	WP
cord-350182-s10nong7	105	11	we	-PRON-	PRP
cord-350182-s10nong7	105	12	may	may	MD
cord-350182-s10nong7	105	13	expect	expect	VB
cord-350182-s10nong7	105	14	regarding	regard	VBG
cord-350182-s10nong7	105	15	pathogenesis	pathogenesis	NN
cord-350182-s10nong7	105	16	,	,	,
cord-350182-s10nong7	105	17	immune	immune	JJ
cord-350182-s10nong7	105	18	responses	response	NNS
cord-350182-s10nong7	105	19	,	,	,
cord-350182-s10nong7	105	20	and	and	CC
cord-350182-s10nong7	105	21	outcomes	outcome	NNS
cord-350182-s10nong7	105	22	Definition	Definition	NNP
cord-350182-s10nong7	105	23	,	,	,
cord-350182-s10nong7	105	24	diagnosis	diagnosis	NN
cord-350182-s10nong7	105	25	and	and	CC
cord-350182-s10nong7	105	26	classification	classification	NN
cord-350182-s10nong7	105	27	of	of	IN
cord-350182-s10nong7	105	28	diabetes	diabetes	NN
cord-350182-s10nong7	105	29	mellitus	mellitus	NN
cord-350182-s10nong7	105	30	and	and	CC
cord-350182-s10nong7	105	31	its	-PRON-	PRP$
cord-350182-s10nong7	105	32	complications	complication	NNS
cord-350182-s10nong7	105	33	.	.	.
cord-350182-s10nong7	106	1	Part	part	NN
cord-350182-s10nong7	106	2	1	1	CD
cord-350182-s10nong7	106	3	:	:	:
cord-350182-s10nong7	107	1	Diagnosis	diagnosis	NN
cord-350182-s10nong7	107	2	and	and	CC
cord-350182-s10nong7	107	3	classification	classification	NN
cord-350182-s10nong7	107	4	of	of	IN
cord-350182-s10nong7	107	5	diabetes	diabetes	NN
cord-350182-s10nong7	107	6	mellitus	mellitus	NN
cord-350182-s10nong7	107	7	.	.	.
cord-350182-s10nong7	108	1	Provisional	provisional	JJ
cord-350182-s10nong7	108	2	report	report	NN
cord-350182-s10nong7	108	3	of	of	IN
cord-350182-s10nong7	108	4	a	a	DT
cord-350182-s10nong7	108	5	WHO	WHO	NNP
cord-350182-s10nong7	108	6	consultation	consultation	NN
cord-350182-s10nong7	108	7	Classification	classification	NN
cord-350182-s10nong7	108	8	and	and	CC
cord-350182-s10nong7	108	9	diagnosis	diagnosis	NN
cord-350182-s10nong7	108	10	of	of	IN
cord-350182-s10nong7	108	11	diabetes	diabetes	NN
cord-350182-s10nong7	108	12	:	:	:
cord-350182-s10nong7	108	13	Standards	standard	NNS
cord-350182-s10nong7	108	14	of	of	IN
cord-350182-s10nong7	108	15	medical	medical	JJ
cord-350182-s10nong7	108	16	care	care	NN
cord-350182-s10nong7	108	17	in	in	IN
cord-350182-s10nong7	108	18	diabetes-2020	diabetes-2020	NNP
cord-350182-s10nong7	108	19	Type	type	NN
cord-350182-s10nong7	108	20	1	1	CD
cord-350182-s10nong7	108	21	diabetes	diabetes	NN
cord-350182-s10nong7	108	22	Idiopathic	Idiopathic	NNP
cord-350182-s10nong7	108	23	type	type	NN
cord-350182-s10nong7	108	24	1	1	CD
cord-350182-s10nong7	108	25	diabetes	diabetes	NN
cord-350182-s10nong7	108	26	Pathophysiology	pathophysiology	NN
cord-350182-s10nong7	108	27	of	of	IN
cord-350182-s10nong7	108	28	type	type	NN
cord-350182-s10nong7	108	29	2	2	CD
cord-350182-s10nong7	108	30	diabetes	diabetes	NN
cord-350182-s10nong7	108	31	:	:	:
cord-350182-s10nong7	109	1	The	the	DT
cord-350182-s10nong7	109	2	evolution	evolution	NN
cord-350182-s10nong7	109	3	of	of	IN
cord-350182-s10nong7	109	4	our	-PRON-	PRP$
cord-350182-s10nong7	109	5	understanding	understanding	NN
cord-350182-s10nong7	109	6	on	on	IN
cord-350182-s10nong7	109	7	behalf	behalf	NN
cord-350182-s10nong7	109	8	of	of	IN
cord-350182-s10nong7	109	9	the	the	DT
cord-350182-s10nong7	109	10	IDF	IDF	NNP
cord-350182-s10nong7	109	11	Diabetes	Diabetes	NNP
cord-350182-s10nong7	109	12	Atlas	Atlas	NNP
cord-350182-s10nong7	109	13	Committee	Committee	NNP
cord-350182-s10nong7	109	14	.	.	.
cord-350182-s10nong7	110	1	Global	global	JJ
cord-350182-s10nong7	110	2	and	and	CC
cord-350182-s10nong7	110	3	regional	regional	JJ
cord-350182-s10nong7	110	4	diabetes	diabetes	NN
cord-350182-s10nong7	110	5	prevalence	prevalence	NN
cord-350182-s10nong7	110	6	estimates	estimate	NNS
cord-350182-s10nong7	110	7	for	for	IN
cord-350182-s10nong7	110	8	2019	2019	CD
cord-350182-s10nong7	110	9	and	and	CC
cord-350182-s10nong7	110	10	projections	projection	NNS
cord-350182-s10nong7	110	11	for	for	IN
cord-350182-s10nong7	110	12	2030	2030	CD
cord-350182-s10nong7	110	13	and	and	CC
cord-350182-s10nong7	110	14	2045	2045	CD
cord-350182-s10nong7	110	15	:	:	:
cord-350182-s10nong7	111	1	Results	result	NNS
cord-350182-s10nong7	111	2	from	from	IN
cord-350182-s10nong7	111	3	the	the	DT
cord-350182-s10nong7	111	4	International	International	NNP
cord-350182-s10nong7	111	5	Diabetes	Diabetes	NNP
cord-350182-s10nong7	111	6	Federation	Federation	NNP
cord-350182-s10nong7	111	7	Diabetes	Diabetes	NNP
cord-350182-s10nong7	111	8	Atlas	Atlas	NNP
cord-350182-s10nong7	111	9	Infections	Infections	NNPS
cord-350182-s10nong7	111	10	in	in	IN
cord-350182-s10nong7	111	11	patients	patient	NNS
cord-350182-s10nong7	111	12	with	with	IN
cord-350182-s10nong7	111	13	diabetes	diabetes	NN
cord-350182-s10nong7	111	14	mellitus	mellitus	NN
cord-350182-s10nong7	111	15	:	:	:
cord-350182-s10nong7	112	1	A	a	DT
cord-350182-s10nong7	112	2	review	review	NN
cord-350182-s10nong7	112	3	of	of	IN
cord-350182-s10nong7	112	4	pathogenesis	pathogenesis	NN
cord-350182-s10nong7	112	5	Immunological	immunological	JJ
cord-350182-s10nong7	112	6	mechanisms	mechanism	NNS
cord-350182-s10nong7	112	7	contributing	contribute	VBG
cord-350182-s10nong7	112	8	to	to	IN
cord-350182-s10nong7	112	9	the	the	DT
cord-350182-s10nong7	112	10	double	double	JJ
cord-350182-s10nong7	112	11	burden	burden	NN
cord-350182-s10nong7	112	12	of	of	IN
cord-350182-s10nong7	112	13	diabetes	diabetes	NN
cord-350182-s10nong7	112	14	and	and	CC
cord-350182-s10nong7	112	15	intracellular	intracellular	JJ
cord-350182-s10nong7	112	16	bacterial	bacterial	JJ
cord-350182-s10nong7	112	17	infections	infection	NNS
cord-350182-s10nong7	112	18	Comorbid	Comorbid	NNP
cord-350182-s10nong7	112	19	chronic	chronic	JJ
cord-350182-s10nong7	112	20	diseases	disease	NNS
cord-350182-s10nong7	112	21	and	and	CC
cord-350182-s10nong7	112	22	acute	acute	JJ
cord-350182-s10nong7	112	23	organ	organ	NN
cord-350182-s10nong7	112	24	injuries	injury	NNS
cord-350182-s10nong7	112	25	are	be	VBP
cord-350182-s10nong7	112	26	strongly	strongly	RB
cord-350182-s10nong7	112	27	correlated	correlate	VBN
cord-350182-s10nong7	112	28	with	with	IN
cord-350182-s10nong7	112	29	disease	disease	NN
cord-350182-s10nong7	112	30	severity	severity	NN
cord-350182-s10nong7	112	31	and	and	CC
cord-350182-s10nong7	112	32	mortality	mortality	NN
cord-350182-s10nong7	112	33	among	among	IN
cord-350182-s10nong7	112	34	COVID-19	covid-19	JJ
cord-350182-s10nong7	112	35	patients	patient	NNS
cord-350182-s10nong7	112	36	:	:	:
cord-350182-s10nong7	112	37	A	a	DT
cord-350182-s10nong7	112	38	systemic	systemic	JJ
cord-350182-s10nong7	112	39	review	review	NN
cord-350182-s10nong7	112	40	and	and	CC
cord-350182-s10nong7	112	41	meta	meta	NNP
cord-350182-s10nong7	112	42	-	-	HYPH
cord-350182-s10nong7	112	43	analysis	analysis	NN
cord-350182-s10nong7	112	44	Comorbid	Comorbid	NNP
cord-350182-s10nong7	112	45	chronic	chronic	JJ
cord-350182-s10nong7	112	46	diseases	disease	NNS
cord-350182-s10nong7	112	47	are	be	VBP
cord-350182-s10nong7	112	48	strongly	strongly	RB
cord-350182-s10nong7	112	49	correlated	correlate	VBN
cord-350182-s10nong7	112	50	with	with	IN
cord-350182-s10nong7	112	51	disease	disease	NN
cord-350182-s10nong7	112	52	severity	severity	NN
cord-350182-s10nong7	112	53	among	among	IN
cord-350182-s10nong7	112	54	COVID-19	covid-19	JJ
cord-350182-s10nong7	112	55	patients	patient	NNS
cord-350182-s10nong7	112	56	:	:	:
cord-350182-s10nong7	112	57	A	a	DT
cord-350182-s10nong7	112	58	systematic	systematic	JJ
cord-350182-s10nong7	112	59	review	review	NN
cord-350182-s10nong7	112	60	and	and	CC
cord-350182-s10nong7	112	61	meta	meta	NNP
cord-350182-s10nong7	112	62	-	-	HYPH
cord-350182-s10nong7	112	63	analysis	analysis	NN
cord-350182-s10nong7	112	64	New	new	JJ
cord-350182-s10nong7	112	65	insights	insight	NNS
cord-350182-s10nong7	112	66	into	into	IN
cord-350182-s10nong7	112	67	insulin	insulin	NN
cord-350182-s10nong7	112	68	:	:	:
cord-350182-s10nong7	112	69	The	the	DT
cord-350182-s10nong7	112	70	antiinflammatory	antiinflammatory	JJ
cord-350182-s10nong7	112	71	effect	effect	NN
cord-350182-s10nong7	112	72	and	and	CC
cord-350182-s10nong7	112	73	its	-PRON-	PRP$
cord-350182-s10nong7	112	74	clinical	clinical	JJ
cord-350182-s10nong7	112	75	relevance	relevance	NN
cord-350182-s10nong7	112	76	de	de	FW
cord-350182-s10nong7	112	77	Góes	Góes	NNP
cord-350182-s10nong7	112	78	Cavalcanti	Cavalcanti	NNP
cord-350182-s10nong7	112	79	LP	LP	NNP
cord-350182-s10nong7	112	80	.	.	.
cord-350182-s10nong7	113	1	Chikungunya	chikungunya	NN
cord-350182-s10nong7	113	2	and	and	CC
cord-350182-s10nong7	113	3	diabetes	diabetes	NN
cord-350182-s10nong7	113	4	,	,	,
cord-350182-s10nong7	113	5	what	what	WP
cord-350182-s10nong7	113	6	do	do	VBP
cord-350182-s10nong7	113	7	we	-PRON-	PRP
cord-350182-s10nong7	113	8	know	know	VB
cord-350182-s10nong7	113	9	?	?	.
cord-350182-s10nong7	114	1	Cytokine	cytokine	NN
cord-350182-s10nong7	114	2	and	and	CC
cord-350182-s10nong7	114	3	cytokine	cytokine	NN
cord-350182-s10nong7	114	4	-	-	HYPH
cord-350182-s10nong7	114	5	like	like	JJ
cord-350182-s10nong7	114	6	inflammation	inflammation	NN
cord-350182-s10nong7	114	7	markers	marker	NNS
cord-350182-s10nong7	114	8	,	,	,
cord-350182-s10nong7	114	9	endothelial	endothelial	JJ
cord-350182-s10nong7	114	10	dysfunction	dysfunction	NN
cord-350182-s10nong7	114	11	,	,	,
cord-350182-s10nong7	114	12	and	and	CC
cord-350182-s10nong7	114	13	imbalanced	imbalanced	JJ
cord-350182-s10nong7	114	14	coagulation	coagulation	NN
cord-350182-s10nong7	114	15	in	in	IN
cord-350182-s10nong7	114	16	development	development	NN
cord-350182-s10nong7	114	17	of	of	IN
cord-350182-s10nong7	114	18	diabetes	diabetes	NN
cord-350182-s10nong7	114	19	and	and	CC
cord-350182-s10nong7	114	20	its	-PRON-	PRP$
cord-350182-s10nong7	114	21	complications	complication	NNS
cord-350182-s10nong7	115	1	Immune	immune	JJ
cord-350182-s10nong7	115	2	cell	cell	NN
cord-350182-s10nong7	115	3	-	-	HYPH
cord-350182-s10nong7	115	4	derived	derive	VBN
cord-350182-s10nong7	115	5	cytokines	cytokine	NNS
cord-350182-s10nong7	115	6	contribute	contribute	VBP
cord-350182-s10nong7	115	7	to	to	IN
cord-350182-s10nong7	115	8	obesity	obesity	NN
cord-350182-s10nong7	115	9	-	-	HYPH
cord-350182-s10nong7	115	10	related	relate	VBN
cord-350182-s10nong7	115	11	inflammation	inflammation	NN
cord-350182-s10nong7	115	12	,	,	,
cord-350182-s10nong7	115	13	fibrogenesis	fibrogenesis	NN
cord-350182-s10nong7	115	14	and	and	CC
cord-350182-s10nong7	115	15	metabolic	metabolic	JJ
cord-350182-s10nong7	115	16	deregulation	deregulation	NN
cord-350182-s10nong7	115	17	in	in	IN
cord-350182-s10nong7	115	18	human	human	JJ
cord-350182-s10nong7	115	19	adipose	adipose	JJ
cord-350182-s10nong7	115	20	tissue	tissue	NN
cord-350182-s10nong7	115	21	Inflammation	inflammation	NN
cord-350182-s10nong7	115	22	and	and	CC
cord-350182-s10nong7	115	23	insulin	insulin	NN
cord-350182-s10nong7	115	24	resistance	resistance	NN
cord-350182-s10nong7	115	25	Diabetes	diabetes	NN
cord-350182-s10nong7	115	26	and	and	CC
cord-350182-s10nong7	115	27	infection	infection	NN
cord-350182-s10nong7	115	28	:	:	:
cord-350182-s10nong7	116	1	Is	be	VBZ
cord-350182-s10nong7	116	2	there	there	EX
cord-350182-s10nong7	116	3	a	a	DT
cord-350182-s10nong7	116	4	link	link	NN
cord-350182-s10nong7	116	5	?	?	.
cord-350182-s10nong7	117	1	-A	-A	:
cord-350182-s10nong7	117	2	mini	mini	JJ
cord-350182-s10nong7	117	3	-	-	JJ
cord-350182-s10nong7	117	4	review	review	NN
cord-350182-s10nong7	117	5	Immune	immune	JJ
cord-350182-s10nong7	117	6	dysfunction	dysfunction	NN
cord-350182-s10nong7	117	7	in	in	IN
cord-350182-s10nong7	117	8	patients	patient	NNS
cord-350182-s10nong7	117	9	with	with	IN
cord-350182-s10nong7	117	10	diabetes	diabetes	NN
cord-350182-s10nong7	117	11	mellitus	mellitus	NN
cord-350182-s10nong7	117	12	(	(	-LRB-
cord-350182-s10nong7	117	13	DM	dm	NN
cord-350182-s10nong7	117	14	)	)	-RRB-
cord-350182-s10nong7	118	1	Lymphopenia	Lymphopenia	NNP
cord-350182-s10nong7	118	2	predicts	predict	VBZ
cord-350182-s10nong7	118	3	disease	disease	NN
cord-350182-s10nong7	118	4	severity	severity	NN
cord-350182-s10nong7	118	5	of	of	IN
cord-350182-s10nong7	118	6	COVID-19	COVID-19	NNP
cord-350182-s10nong7	118	7	:	:	:
cord-350182-s10nong7	118	8	A	a	DT
cord-350182-s10nong7	118	9	descriptive	descriptive	JJ
cord-350182-s10nong7	118	10	and	and	CC
cord-350182-s10nong7	118	11	predictive	predictive	JJ
cord-350182-s10nong7	118	12	study	study	NN
cord-350182-s10nong7	119	1	Common	common	JJ
cord-350182-s10nong7	119	2	infections	infection	NNS
cord-350182-s10nong7	119	3	in	in	IN
cord-350182-s10nong7	119	4	diabetes	diabetes	NN
cord-350182-s10nong7	119	5	:	:	:
cord-350182-s10nong7	120	1	Pathogenesis	pathogenesis	NN
cord-350182-s10nong7	120	2	,	,	,
cord-350182-s10nong7	120	3	management	management	NN
cord-350182-s10nong7	120	4	and	and	CC
cord-350182-s10nong7	120	5	relationship	relationship	NN
cord-350182-s10nong7	120	6	to	to	IN
cord-350182-s10nong7	120	7	glycaemic	glycaemic	JJ
cord-350182-s10nong7	120	8	control	control	NNP
cord-350182-s10nong7	120	9	COVID-19	COVID-19	NNP
cord-350182-s10nong7	120	10	and	and	CC
cord-350182-s10nong7	120	11	diabetes	diabete	VBZ
cord-350182-s10nong7	120	12	:	:	:
cord-350182-s10nong7	120	13	Knowledge	knowledge	NN
cord-350182-s10nong7	120	14	in	in	IN
cord-350182-s10nong7	120	15	progress	progress	NN
cord-350182-s10nong7	120	16	Is	be	VBZ
cord-350182-s10nong7	120	17	COVID-19	covid-19	VB
cord-350182-s10nong7	120	18	an	an	DT
cord-350182-s10nong7	120	19	endothelial	endothelial	JJ
cord-350182-s10nong7	120	20	disease	disease	NN
cord-350182-s10nong7	120	21	?	?	.
cord-350182-s10nong7	121	1	Clinical	clinical	JJ
cord-350182-s10nong7	121	2	and	and	CC
cord-350182-s10nong7	121	3	basic	basic	JJ
cord-350182-s10nong7	121	4	evidence	evidence	NN
cord-350182-s10nong7	121	5	Risk	risk	NN
cord-350182-s10nong7	121	6	factors	factor	NNS
cord-350182-s10nong7	121	7	of	of	IN
cord-350182-s10nong7	121	8	critical	critical	JJ
cord-350182-s10nong7	121	9	&	&	CC
cord-350182-s10nong7	121	10	mortal	mortal	JJ
cord-350182-s10nong7	121	11	COVID-19	COVID-19	NNP
cord-350182-s10nong7	121	12	cases	case	NNS
cord-350182-s10nong7	121	13	:	:	:
cord-350182-s10nong7	121	14	A	a	DT
cord-350182-s10nong7	121	15	systematic	systematic	JJ
cord-350182-s10nong7	121	16	literature	literature	NN
cord-350182-s10nong7	121	17	review	review	NN
cord-350182-s10nong7	121	18	and	and	CC
cord-350182-s10nong7	121	19	meta	meta	NNP
cord-350182-s10nong7	121	20	-	-	HYPH
cord-350182-s10nong7	121	21	analysis	analysis	NN
cord-350182-s10nong7	121	22	Are	be	VBP
cord-350182-s10nong7	121	23	patients	patient	NNS
cord-350182-s10nong7	121	24	with	with	IN
cord-350182-s10nong7	121	25	hypertension	hypertension	NN
cord-350182-s10nong7	121	26	and	and	CC
cord-350182-s10nong7	121	27	diabetes	diabetes	NN
cord-350182-s10nong7	121	28	mellitus	mellitus	NN
cord-350182-s10nong7	121	29	at	at	IN
cord-350182-s10nong7	121	30	increased	increase	VBN
cord-350182-s10nong7	121	31	risk	risk	NN
cord-350182-s10nong7	121	32	for	for	IN
cord-350182-s10nong7	121	33	COVID-19	covid-19	JJ
cord-350182-s10nong7	121	34	infection	infection	NN
cord-350182-s10nong7	121	35	?	?	.
cord-350182-s10nong7	122	1	Commentary	commentary	NN
cord-350182-s10nong7	122	2	.	.	.
cord-350182-s10nong7	123	1	COVID-19	covid-19	VB
cord-350182-s10nong7	123	2	and	and	CC
cord-350182-s10nong7	123	3	diabetes	diabete	VBZ
cord-350182-s10nong7	123	4	mellitus	mellitus	NN
cord-350182-s10nong7	123	5	:	:	:
cord-350182-s10nong7	124	1	What	what	WP
cord-350182-s10nong7	124	2	we	-PRON-	PRP
cord-350182-s10nong7	124	3	know	know	VBP
cord-350182-s10nong7	124	4	,	,	,
cord-350182-s10nong7	124	5	how	how	WRB
cord-350182-s10nong7	124	6	our	-PRON-	PRP$
cord-350182-s10nong7	124	7	patients	patient	NNS
cord-350182-s10nong7	124	8	should	should	MD
cord-350182-s10nong7	124	9	be	be	VB
cord-350182-s10nong7	124	10	treated	treat	VBN
cord-350182-s10nong7	124	11	now	now	RB
cord-350182-s10nong7	124	12	,	,	,
cord-350182-s10nong7	124	13	and	and	CC
cord-350182-s10nong7	124	14	what	what	WP
cord-350182-s10nong7	124	15	should	should	MD
cord-350182-s10nong7	124	16	happen	happen	VB
cord-350182-s10nong7	124	17	next	next	RB
cord-350182-s10nong7	124	18	COVID-19	COVID-19	NNP
cord-350182-s10nong7	124	19	in	in	IN
cord-350182-s10nong7	124	20	diabetic	diabetic	JJ
cord-350182-s10nong7	124	21	patients	patient	NNS
cord-350182-s10nong7	124	22	:	:	:
cord-350182-s10nong7	124	23	Related	related	JJ
cord-350182-s10nong7	124	24	risks	risk	NNS
cord-350182-s10nong7	124	25	and	and	CC
cord-350182-s10nong7	124	26	specifics	specific	NNS
cord-350182-s10nong7	124	27	of	of	IN
cord-350182-s10nong7	124	28	management	management	NN
cord-350182-s10nong7	124	29	Prevention	Prevention	NNP
cord-350182-s10nong7	124	30	and	and	CC
cord-350182-s10nong7	124	31	management	management	NN
cord-350182-s10nong7	124	32	of	of	IN
cord-350182-s10nong7	124	33	COVID-19	COVID-19	NNP
cord-350182-s10nong7	124	34	among	among	IN
cord-350182-s10nong7	124	35	patients	patient	NNS
cord-350182-s10nong7	124	36	with	with	IN
cord-350182-s10nong7	124	37	diabetes	diabetes	NN
cord-350182-s10nong7	124	38	:	:	:
cord-350182-s10nong7	124	39	An	an	DT
cord-350182-s10nong7	124	40	appraisal	appraisal	NN
cord-350182-s10nong7	124	41	of	of	IN
cord-350182-s10nong7	124	42	the	the	DT
cord-350182-s10nong7	124	43	literature	literature	NN
cord-350182-s10nong7	125	1	Publisher	publisher	NN
cord-350182-s10nong7	125	2	's	's	POS
cord-350182-s10nong7	125	3	Note	Note	NNP
cord-350182-s10nong7	125	4	Springer	Springer	NNP
cord-350182-s10nong7	125	5	Nature	Nature	NNP
cord-350182-s10nong7	125	6	remains	remain	VBZ
cord-350182-s10nong7	125	7	neutral	neutral	JJ
cord-350182-s10nong7	125	8	with	with	IN
cord-350182-s10nong7	125	9	regard	regard	NN
cord-350182-s10nong7	125	10	to	to	IN
cord-350182-s10nong7	125	11	jurisdictional	jurisdictional	JJ
cord-350182-s10nong7	125	12	claims	claim	NNS
cord-350182-s10nong7	125	13	in	in	IN
cord-350182-s10nong7	125	14	published	publish	VBN
cord-350182-s10nong7	125	15	maps	map	NNS
cord-350182-s10nong7	125	16	and	and	CC
cord-350182-s10nong7	125	17	institutional	institutional	JJ
cord-350182-s10nong7	125	18	affiliations	affiliation	NNS
cord-350182-s10nong7	125	19	Conflict	conflict	NN
cord-350182-s10nong7	125	20	of	of	IN
cord-350182-s10nong7	125	21	interest	interest	NN
cord-350182-s10nong7	126	1	The	the	DT
cord-350182-s10nong7	126	2	authors	author	NNS
cord-350182-s10nong7	126	3	declare	declare	VBP
cord-350182-s10nong7	126	4	that	that	IN
cord-350182-s10nong7	126	5	they	-PRON-	PRP
cord-350182-s10nong7	126	6	have	have	VBP
cord-350182-s10nong7	126	7	no	no	DT
cord-350182-s10nong7	126	8	conflict	conflict	NN
cord-350182-s10nong7	126	9	of	of	IN
cord-350182-s10nong7	126	10	interest	interest	NN
cord-350182-s10nong7	126	11	.	.	.